Source: http://www.google.com/patents/US6275717?dq=6,595,873
Timestamp: 2016-08-26 01:10:13
Document Index: 593968736

Matched Legal Cases: ['art 12', 'art 13', 'art 13', 'art 13', 'art 12', 'art 13', 'art 13', 'art 12', 'art 13', 'art 12', 'art 13', 'art 13', 'art 13', 'art 13', 'art 12', 'art 13', 'art 13', 'art 12', 'art 13', 'art 12', 'art 13', 'art 12', 'art 13', 'art 12', 'art 13', 'art 12', 'art 13', 'art 13', 'art 13', 'art 12', 'art 12', 'art 13', 'art 12', 'art 12', 'art 13', 'art 13']

Patent US6275717 - Device and method of calibrating and testing a sensor for in vivo ... - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsA method of calibrating an analyte sensor in vivo, by providing a first predetermined stimulus to the sensor when the sensor is applied to a subject to produce a first sensor signal, measuring the first sensor signal, and determining a calibration function based on the first measured sensor signal resulting...http://www.google.com/patents/US6275717?utm_source=gb-gplus-sharePatent US6275717 - Device and method of calibrating and testing a sensor for in vivo measurement of an analyteAdvanced Patent SearchPublication numberUS6275717 B1Publication typeGrantApplication numberUS 09/102,840Publication dateAug 14, 2001Filing dateJun 23, 1998Priority dateJun 16, 1997Fee statusPaidAlso published asCA2294610A1, EP0990151A2, WO1998058250A2, WO1998058250A3Publication number09102840, 102840, US 6275717 B1, US 6275717B1, US-B1-6275717, US6275717 B1, US6275717B1InventorsJoseph Gross, Meir Reingewirtz, Moshe George KatzOriginal AssigneeElan Corporation, PlcExport CitationBiBTeX, EndNote, RefManPatent Citations (56), Referenced by (801), Classifications (17), Legal Events (9) External Links: USPTO, USPTO Assignment, EspacenetDevice and method of calibrating and testing a sensor for in vivo measurement of an analyte
US 6275717 B1Abstract
A method of calibrating an analyte sensor in vivo, by providing a first predetermined stimulus to the sensor when the sensor is applied to a subject to produce a first sensor signal, measuring the first sensor signal, and determining a calibration function based on the first measured sensor signal resulting from the predetermined stimulus. The calibration function, when applied to further signals received from the sensor, can be used to provide a calibrated output.
What is claimed is: 1. A method of calibrating an analyte sensor in vivo, comprising the steps of:
(a) providing a first predetermined stimulus to the sensor when the sensor is applied to a subject to produce a first sensor signal; (b) measuring the first sensor signal; and (c) determining a calibration function based on the first measured sensor signal resulting from the predetermined stimulus, whereby the calibration function when applied to further signals received from the sensor can be used to provide a calibrated output.
2. A method according to claim 1, wherein the first predetermined stimulus is generated by providing a supply of material to which the sensor is sensitive, such that the material stimulates the sensor when the sensor is applied to a subject.
3. A method according to claim 2, wherein the material is provided in the vicinity of the sensor in a form in which it is soluble in biological fluids present in the area of the subject to which the sensor is applied.
4. A method according to claim 2, wherein the material comprises an analyte or a precursor or derivative thereof.
5. A method according to claim 1, wherein the predetermined stimulus is adapted to saturate the sensor such that the first signal is a maximum signal.
6. A method according to claim 1, further comprising the steps of providing a second predetermined stimulus to the sensor so as to produce a second sensor signal and measuring the second sensor signal, such that the determination of the calibration function is based on the first and second measured sensor signals.
7. A method according to claim 6, wherein the second sensor signal is a base line signal measured when substantially no analyte is in the vicinity of the sensor.
8. A method according to claim 7, wherein the second predetermined stimulus is provided by consuming substantially all of the analyte in the vicinity of the sensor.
9. A method according to claim 8, wherein the analyte is measured by the sensor by means of an electrochemical reaction, with the sensor forming part of an electrical circuit, and wherein the analyte is consumed by providing a current through the circuit which causes the analyte to undergo the electrochemical reaction, with the measurement of the second sensor signal being carried out shortly after the analyte is consumed.
10. A method according to claim 6, wherein the first and second signals constitute known points on a measured performance curve describing the measured performance of the sensor, and wherein the calibration function correlates the measured performance curve with a theoretical sensor performance curve for which there is stored a calibrated output, such that any further sensor signal measurement from the sensor can be calibrated by correlating the point on the measured performance curve to which the measurement relates with a corresponding point on the theoretical sensor performance curve, and hence with the corresponding calibrated output.
11. A method according to claim 10, wherein the known points on a curve describing the measured performance of the sensor are endpoints of the curve.
12. A method according to claim 1, wherein the analyte is glucose.
13. A method of measuring an analyte in vivo comprising the steps of applying a sensor to a subject, calibrating the sensor according to the method of claim 1, and providing a calibrated output of any further measurements made by the sensor based on the calibration function.
14. A device for the in vivo measurement of an analyte, comprising:
(a) an in vivo sensor for measuring the analyte and providing a signal in response to the measurement of the analyte; (b) means for providing a first predetermined stimulus to the sensor when the sensor is applied to a subject so as to produce a first sensor signal; and (c) electronic circuitry associated with the sensor for receiving the signal and providing a calibrated output based on the signal, wherein the electronic circuitry includes means for determining a calibration function for the sensor based on the first measured sensor signal resulting from the predetermined stimulus; such that the function when applied to further signals received from the sensor can be used to provide a calibrated output.
15. A device according to claim 14, wherein the means for providing a first predetermined stimulus to the sensor comprises a supply of material associated with the sensor such when the sensor is applied to a subject, the sensor is sensitive to the material.
16. A device according to claim 15, wherein the supply of material is associated with a permeable protective coating provided on the sensor.
17. A device according to claim 15, wherein the supply of material is provided in an amount sufficient to saturate the sensor and thereby generate a maximum signal which can be used to calibrate the sensor.
18. A device according to claim 15, wherein the sensor comprises an element which is adapted to be inserted subcutaneously, intradermally, intravenously or by surgical implantation into the subject, and wherein the supply of material is provided on the sensor in soluble form.
19. A device according to claim 15, further comprising a housing having a lower surface for application to the skin of a subject, wherein the sensor is in the form of a needle extending from the housing such that the sensor penetrates the skin of the subject when the device is applied thereto.
20. A device according to claim 15, wherein means are provided for generating a base line signal corresponding to the signal obtained when substantially no analyte is present in the vicinity of the needle, and wherein the base line signal is used to calibrate the sensor.
21. A device according to claim 20, wherein the means for generating a base line signal comprises a voltage generator which forms part of the electronic circuitry, and wherein the base line signal is provided by passing a current in the vicinity of the needle which eliminates the analyte or a chemical substance used in the measurement of the analyte.
22. A device according to claim 15, wherein the analyte is glucose.
23. A method for the in vivo testing of an analyte sensor which is provided to a subject as an electrode of an electrical circuit, comprising the steps of:
(a) applying a potential to the electrode and varying the electrode potential so as to cause the electrode current to undergo at least part of a cycle which exhibits hysteresis; (b) measuring and recording a plurality of current values on the hysteresis cycle; (c) calculating a characteristic point on the hysteresis curve from the plurality of current values; and (e) comparing the characteristic point with a stored value and determining from this comparison whether the sensor meets a predetermined condition. 24. A method according to claim 23, wherein the characteristic point is a nodal point on the hysteresis curve.
25. A method according to claim 23, wherein the nodal point is defined as a voltage for which the current value is independent of the analyte concentration in the vicinity of the sensor when the sensor is operating correctly.
26. A method according to claim 23, wherein steps (a)-(e) are repeated periodically.
27. A method according to claim 23, wherein an initial iteration of steps (a)-(d) yields a value for the characteristic point which is stored for comparative subsequent use.
28. A method according to claim 27, wherein the initial iteration is repeated a plurality of times shortly after the sensor has been applied to the subject, and wherein a supply of the analyte to be measured is provided to the sensor in varying concentrations during the repetition of the iterations.
29. A method according to claim 28, wherein the analyte is supplied on the sensor in such a manner that it is released upon application of the sensor to the subject, and wherein the varying concentrations of analyte are achieved by consuming the analyte in a reaction or allowing the analyte to diffuse within the body of the subject.
30. A method according to claim 23, further comprising the step of providing an indicator if it is determined that the sensor does not meet the predetermined condition.
31. A method according to claim 30, wherein the indicator comprises an audible alarm.
32. A device for the in vivo measurement of an analyte, comprising:
(a) an in vivo sensor for measuring the analyte and providing a signal in response to the measurement of the analyte; (b) electronic circuitry associated with the sensor for receiving the signal and providing a calibrated output based on the signal; (c) an electrical circuit in which the sensor acts as an electrode, the electrical circuit comprising means for energizing the electrode to a predetermined potential and for measuring and recording the resultant current through the electrode; (d) means for varying the electrode potential so as to cause the current to undergo at least part of a hysteresis cycle; (e) means for calculating a characteristic point on the hysteresis curve from the recorded current measurements; and (f) means for comparing the characteristic point with a stored value and for determining from this comparison whether the sensor meets a predetermined condition. 33. A device according to claim 32, wherein the characteristic point is a nodal point on the hysteresis curve.
34. A device according to claim 32, wherein the nodal point is defined as a voltage for which the current value on the hysteresis curve is independent of the analyte concentration in the vicinity of the sensor when the sensor is functioning correctly.
35. A device according to claim 32, further comprising a memory for storing the value of a characteristic point determined on an initial iteration of measurements of current values.
36. A device according to claim 32, further comprising means for providing an alarm if it is determined that the sensor does not meet the predetermined condition.
37. A method for the in vivo measurement of an analyte, comprising:
(a) providing an in vivo sensor, which acts as an electrode of an electrical circuit, to a subject for measuring the analyte, wherein the operation of the sensor is dependent on a reaction in which oxygen is required; (b) passing a voltage through the electrode, the voltage being of a magnitude and duration sufficient to cause the electrolysis of a chemical species present in the vicinity of the sensor so as to generate oxygen; (c) measuring the signal produced by the sensor in response to the oxygen-dependent reaction; and (d) repeating steps (b) and (c) periodically. 38. A method according to claim 37, wherein water is the chemical species present in the vicinity of the sensor which is electrolyzed to provide oxygen.
39. A method according to claim 37, wherein step (b) continues for a duration sufficient to generate oxygen in an excess stoichiometric ratio relative to the analyte being measured at the sensor.
40. A device for the in vivo measurement of an analyte, comprising:
(a) an in vivo sensor for measuring the analyte and providing a signal in response to the measurement of the analyte, wherein the operation of the sensor is dependent on a reaction in which oxygen is required; (b) electronic circuitry associated with the sensor for receiving the signal and providing a calibrated output based on the signal; (c) an electrical circuit in which the sensor acts as an electrode, the electrical circuit comprising means for energizing the electrode to a voltage which is of a magnitude and duration sufficient to cause the electrolysis of a chemical species present in the vicinity of the sensor to provide oxygen; and (d) means for alternately generating oxygen by electrolysis and measuring the analyte by allowing the generated oxygen to take part in the reaction. 41. A device according to claim 14, further comprising means for delivering a substance to the subject in response to the measured analyte values.
42. A device according to claim 32 further comprising means for delivering a substance to the subject in response to the measured analyte values.
43. A device according to claim 40 further comprising means for delivering a substance to the subject in response to the measured analyte values.
44. A device according to claim 41, wherein the substance is a medicament suitable to correct a condition in the patient for which the analyte is an indicating agent.
45. A device according to claim 42, wherein the substance is a medicament suitable to correct a condition in the patient for which the analyte is an indicating agent.
46. A device according to claim 43, wherein the substance is a medicament suitable to correct a condition in the patient for which the analyte is an indicating agent.
47. A device for calibrating an analyte sensor in vivo, comprising:
(a) a sensor for application to a subject; (b) means for providing a first predetermined stimulus to the sensor to produce a first sensor signal; (c) means for measuring the first sensor signal; and (d) means for determining a calibration function based on the first measured sensor signal resulting from the predetermined stimulus, whereby the calibration function when applied to further signals received from the sensor can be used to provide a calibrated output.
48. A device according to claim 47, wherein the means for providing the first predetermined stimulus comprises a supply of material to which the sensor is sensitive, such that the material stimulates the sensor when the sensor is applied to a subject.
49. A device according to claim 48, wherein the material is soluble in biological fluids present in the area of the subject to which the sensor is applied.
50. A device according to claim 47, wherein the material comprises an analyte or a precursor or derivative thereof.
51. A device according to claim 47, wherein the predetermined stimulus is adapted to saturate the sensor such that the first signal is a maximum signal.
52. A device according to claim 47, further comprising means for providing a second predetermined stimulus to the sensor so as to produce a second sensor signal and means for measuring the second sensor signal, such that the means for determination of the calibration function determines a calibration function based on the first and second measured sensor signals.
53. A device according to claim 52, wherein the second sensor signal is a base line signal measured when substantially no analyte is in the vicinity of the sensor.
54. A device according to claim 52, wherein the second predetermined stimulus is provided by consuming substantially all of the analyte in the vicinity of the sensor.
55. A device according to claim 47, wherein the first and second signals constitute known points on a measured performance curve describing the measured performance of the sensor, and wherein the calibration function correlates the measured performance curve with a theoretical sensor performance curve for which there is stored a calibrated output, such that any further sensor signal measurement from the sensor can be calibrated by correlating the point on the measured performance curve to which the measurement relates with a corresponding point on the theoretical sensor performance curve, and hence with the corresponding calibrated output.
56. A device according to claim 55, wherein the known points on a curve describing the measured performance of the sensor are endpoints of the curve.
57. A device according to claim 47, wherein the analyte is glucose.
58. A device for measuring an analyte in vivo comprising means for applying a sensor to a subject, means for calibrating the sensor according to the method of claim 1, and means for providing a calibrated output of any further measurements made by the sensor based on the calibration function.
59. A sensor for use in a device according to claim 47.
This invention relates to devices and methods for measuring an analyte in vivo, and in particular to sensors for use in such devices and methods.
Our WO 96/14026, incorporated herein by reference, describes an analyte-controlled liquid delivery device and analyte monitor in which an analyte such as glucose is detected by a platinum-iridium sensor needle having an enzymatic coating such as glucose oxidase. The sensor needle is typically located on a housing having a lower surface for application to the skin of a subject. Glucose in the presence of the enzymatic coating undergoes a reaction with oxygen, and one of the by-products of the reaction is hydrogen peroxide. This in turn is broken down by the platinum in the sensor needle which forms an electrode of an electrical circuit. The level of concentration of glucose is proportional to the magnitude of the current. Thus, the magnitude of the current through the electrical circuit can be used to determine the concentration of glucose.
It has been found that when enzymatic sensors are mass-produced (like many other products), there are slight variations between batches, although individual sensors in each batch are identical. Accordingly to avoid errors in measurements made using such sensors, each production batch can be calibrated.
One method of calibrating such sensors is to use them to measure a standard solution of the analyte for which they are intended, and thereby determining the signal strength achieved from a known concentration of analyte. By making one or more measurements in this way for a statistically valid sample of sensors in a batch it is possible to determine a calibration function which can in theory be used to derive the analyte concentration in vivo from the measured signal.
However, due to the sensitive nature of enzymes, the performance of a sensor may vary over the shelf life of the sensor. Additionally, when the sensor is actually used, it is in a different environment from that in which the batch was calibrated. The sensor will form part of a system in use which is partly biological and which will vary between individual subjects. For example, the laboratory batch calibration function may not take account of the presence of unwanted substances in vivo which give a false background signal.
For these reasons, it has been found that sensors characterised by a laboratory batch calibration are unsatisfactory because such calibration does not permit the performance of the sensor in vivo to be accurately predicted in all cases.
It is thus an object of the present invention to provide a quick and accurate method of in vivo calibration of an analyte sensor.
A further problem associated with enzymatic sensors is that they are subject to a deterioration in performance. This can happen as a result of the enzymatic material being physically or chemically degraded, or as a result of a build up of biological material on the sensor, for example. In WO 96/14026, incorporated herein by reference, a method of detecting a decrease in the performance level of a sensor is disclosed. In this method, a pulsatile sampling technique is used in which pulses of current are detected at or about a peak value and at or about a base line value. The ratio of the two measured currents was found to be independent of the concentration of the analyte being measured, such that if this ratio was found to change over time, one could deduce that the performance of the sensor had changed in some way (usually due to degradation). The present invention seeks to provide an alternative and more reliable method of monitoring sensor performance and degradation.
The present invention seeks to provide an alternative method of testing a sensor to detect changes in the sensor performance.
In measuring an analyte by means of a chemical or electrochemical reaction which requires oxygen, difficulties can arise when the measurement must be carried out in vivo. The quantity of dissolved oxygen in the blood or tissue at the location of the sensor may not be sufficient. If there is an insufficient supply of oxygen, then the rate of reaction of the analyte (and hence the detected level of analyte) may be limited by the available oxygen. This can give rise to false readings which are potentially extremely dangerous, such as in cases where the measured analyte level is used as the basis for the possible administration of a therapeutic agent.
In the case of glucose, this could lead to a diabetic patient being measured as having normal glucose levels when in fact glucose levels had increased to a point where insulin is required to reduce those levels. An error in detection of the glucose level can therefore give rise to problems and indeed dangers to diabetic patients. The same is also true in respect of other substances for which there is a medical need for in vivo analysis and measurement. For these reasons, it is clearly advantageous and important to improve the performance and accuracy of such devices and sensors.
Accordingly, the present invention provides for a method of calibrating an analyte sensor in vivo, comprising the steps of:
(a) providing a first predetermined stimulus to the sensor when the sensor is applied to a subject to produce a first sensor signal;
(b) measuring the first sensor signal; and
(c) determining a calibration function based on the first measured sensor signal resulting from the predetermined stimulus,
whereby the calibration function when applied to further signals received from the sensor can be used to provide a calibrated output.
The provision of a predetermined stimulus in vivo enables the sensor response to be calibrated, since the theoretical response of the sensor to such a stimulus can be determined beforehand. Accordingly, the method according to the invention provides a way of using the response attained from a predetermined stimulus to evaluate the response to subsequent stimuli, i.e. actual measurements recorded by the sensor in vivo, taking into account the condition of the sensor and the conditions encountered in use.
Preferably, the first predetermined stimulus is generated by providing a supply of material to which the sensor is sensitive, such that the material stimulates the sensor when the sensor is applied to a subject.
By supplying a material to which the sensor is sensitive, one can reliably generate a stimulus for the sensor which can be accurately predetermined beforehand.
Suitably, the material is provided in the vicinity of the sensor in a form in which it is soluble in biological fluids present in the area of the subject to which the sensor is applied.
A soluble material will be released to the sensor upon application to the body, and since the speed of dissolution and the transport of dissolved material in the body can be accurately predicted, so can the time at which the material reaches the sensor and the concentration of material thereby encountered by the sensor.
In preferred embodiments, the material comprises an analyte or a precursor or derivative thereof.
The important factor is that the sensor generates a reliable response to whichever material is chosen, but by choosing the analyte or a closely related substance as the relevant material, a relatively simple sensor which is only required to be sensitive to one substance or a small range of substances can be used. As a further example, instead of using the analyte to be detected, one could choose a salt of the analyte which exhibits a high solubility in vivo.
Suitably, the predetermined stimulus is adapted to saturate the sensor such that the first signal is a maximum signal.
When a sensor is such that it can be saturated by a sufficiently large stimulus, it can be preferable to use this phenomenon in calibrating the sensor as it enables a reproducible first predetermined stimulus, i.e. a saturation stimulus to be provided in all cases, thereby removing uncertainty as to whether the means for providing a predetermined stimulus will in fact achieve exactly the right level of uncertainty.
In preferred embodiments, the method according to the invention further comprises the steps of providing a second predetermined stimulus to the sensor so as to produce a second sensor signal and measuring the second sensor signal, such that the determination of the calibration function is based on the first and second measured sensor signals.
It has been found that a more accurate calibration is achieved when two signals are received from predetermined stimuli, as this generally allows the sensor to be calibrated over a working range with accuracy.
Preferably, the second sensor signal is a base line signal measured when substantially no analyte is in the vicinity of the sensor.
The use of a base line signal in combination with a saturation signal is preferred as this enables the sensor to be calibrated for all useful signals, and these two endpoints can enable the sensor reaction to be extrapolated for intermediate points.
Suitably, the second predetermined stimulus is provided by consuming substantially all of the analyte in the vicinity of the sensor.
The consumption of analyte in the vicinity of the needle causes the sensor to generate a base line signal which is attributable only to factors other than the presence of analyte (e.g. extraneous substances which generate false analyte measurements, residual background signals generated by the sensor, etc.).
Preferably, the analyte is measured by the sensor by means of an electrochemical reaction, with the sensor forming part of an electrical circuit, and the analyte is consumed by providing a current through the circuit which causes the analyte to undergo the electrochemical reaction, with the measurement of the second sensor signal being carried out shortly after the analyte is consumed.
The advantage of this method of consuming analyte is that the apparatus required to consume the analyte can be the same apparatus which is present in any event as part of the sensor and associated components.
Preferably, the first and second signals constitute known points on a measured performance curve describing the measured performance of the sensor, and the calibration function correlates the measured performance curve with a theoretical sensor performance curve for which there is stored a calibrated output, such that any further sensor signal measurement from the sensor can be calibrated by correlating the point on the measured performance curve to which the measurement relates with a corresponding point on the theoretical sensor performance curve, and hence with the corresponding calibrated output.
The theoretical sensor performance curve can be determined during the design of the sensor, can be measured for individual sensors during production, or can be measured for a manufactured batch of sensors on a statistical basis. Two curves having basic common parameters (such as a common shape) can thus be correlated to one another by comparing known points on each curve and extrapolating for subsequently measured points.
Preferably, the known points on a curve describing the measured performance of the sensor are endpoints of the curve. If the curve has a well defined shape, two endpoints may enable the intervening points to be calculated with accuracy. Indeed if one of the endpoints is always exactly zero (as in the case of a linear curve whose only variable is the slope), then a single saturation endpoint may describe the entire curve mathematically.
As will be further described below, a particularly preferred analyte is glucose. The advantages of having a reliable alternative method of measuring glucose in vivo are plain given the number of diabetics for whom blood sampling tests several times daily are a fact of life. The most common method of blood sampling currently in use is a procedure in which the skin must be punctured on every occasion. Until now, the use of a continuous monitoring system was hampered by calibration difficulties, and so the present invention provides a way of removing this difficulty.
The invention thus provides also a method of measuring an analyte in vivo comprising the steps of applying a sensor to a subject, calibrating the sensor according to the invention, and providing a calibrated output of any further measurements made by the sensor based on the calibration function.
In another aspect, the invention provides a device for the in vivo measurement of an analyte, comprising:
(a) an in vivo sensor for measuring the analyte and providing a signal in response to the measurement of the analyte;
(b) means for providing a first predetermined stimulus to the sensor when the sensor is applied to a subject so as to produce a first sensor signal; and
(c) electronic circuitry associated with the sensor for receiving the signal and providing a calibrated output based on the signal, wherein the electronic circuitry includes means for determining a calibration function for the sensor based on the first measured sensor signal resulting from the predetermined stimulus;
such that the function when applied to further signals received from the sensor can be used to provide a calibrated output.
As the skilled person will appreciate, this device is adapted to carry out the calibration method discussed above, and therefore has many of the same advantages associated therewith. Further features of such a device are set out below, the advantages of which will in many cases also be apparent from the above discussion.
Preferably, the means for providing a first predetermined stimulus to the sensor comprises a supply of material associated with the sensor such when the sensor is applied to a subject, the sensor is sensitive to the material.
Further, preferably, the supply of material is associated with a permeable protective coating provided on the sensor.
In a preferred embodiment, the supply of material is provided in an amount sufficient to saturate the sensor and thereby generate a maximum signal which can be used to calibrate the sensor.
Preferably, the sensor comprises an element which is adapted to be inserted subcutaneously, intradermally, intravenously or by surgical implantation into the subject, and the supply of material is provided on the sensor in soluble form.
Thus, the sensor can be provided in the form of a needle on a device which can be affixed to the skin painlessly and worn unobtrusively, such that the sensor penetrates the skin to a predetermined depth. By choosing the site at which the device is to be affixed, a good degree of uniformity between individuals is ensured.
Presently preferred devices of this type comprise a housing having a lower surface for application to the skin of a subject, the sensor being in the form of a needle extending from the housing such that the sensor penetrates the skin of the subject when the device is applied thereto.
Suitably, means are provided for generating a base line signal corresponding to the signal obtained when substantially no analyte is present in the vicinity of the needle, and the base line signal is used to calibrate the sensor.
Preferably, the means for generating a base line signal comprises a voltage generator which forms part of the electronic circuitry, and the base line signal is provided by passing a current in the vicinity of the needle which eliminates the analyte or a chemical substance used in the measurement of the analyte.
Further, preferably, the analyte to be detected by the device is glucose.
The invention also provides a method for the in vivo testing of an analyte sensor which is provided to a subject as an electrode of an electrical circuit, comprising the steps of:
(a) applying a potential to the electrode and varying the electrode potential so as to cause the electrode current to undergo at least part of a cycle which exhibits hysteresis;
(b) measuring and recording a plurality of current values on the hysteresis cycle;
(c) calculating a characteristic point on the hysteresis curve from the plurality of current values; and
(e) comparing the characteristic point with a stored value and determining from this comparison whether the sensor meets a predetermined condition.
It has been found that degradation of an electrode in use is in many cases accompanied by changes in the current-voltage response of the electrical circuit of which the electrode forms part. At any given voltage (e.g. the voltage used in the measurement of the analyte), such changes could be interpreted as a change in analyte levels. Surprisingly, however, the shape of a hysteresis cycle for the electrode will change, and if a characteristic point on such a cycle has been identified when the sensor is operating correctly, deterioration of the sensor may be identified by a change in the current-voltage response at such a characteristic point.
Suitably, the characteristic point is a nodal point on the hysteresis curve, with the nodal point preferably defined as a voltage for which the current value is independent of the analyte concentration in the vicinity of the sensor when the sensor is operating correctly.
Suitably, steps (a)-(e) of the method of testing the sensor needle are repeated periodically. This allows the sensor to be repeatedly tested while in use, thereby monitoring the sensor for deviations from the expected performance.
Preferably, an initial iteration of steps (a)-(d) yields a value for the characteristic point which is stored for comparative subsequent use.
Thus, rather than using a laboratory calibration to determine the characteristic point(s), this can be done in vivo for a more accurate determination.
Further, preferably, the initial iteration is repeated a plurality of times shortly after the sensor has been applied to the subject, and a supply of the analyte to be measured is provided to the sensor in varying concentrations during the repetition of the iterations.
Most preferably, the analyte is supplied on the sensor in such a manner that it is released upon application of the sensor to the subject, and wherein the varying concentrations of analyte are achieved by consuming the analyte in a reaction or allowing the analyte to diffuse within the body of the subject.
In this manner, the determination of a characteristic point can be carried out at the time that the sensor is being calibrated in vivo, since as described above the in vivo calibration may employ varying levels in analyte concentration at the sensor, and these varying analyte levels also enable the current-voltage response to be measured at different analyte levels as part of repeated hysteresis cycles.
The method suitably comprises the further step of providing an indicator if it is determined that the sensor does not meet the predetermined condition. Preferably, the indicator comprises an audible alarm.
(b) electronic circuitry associated with the sensor for receiving the signal and providing a calibrated output based on the signal;
(c) an electrical circuit in which the sensor acts as an electrode, the electrical circuit comprising means for energising the electrode to a predetermined potential and for measuring and recording the resultant current through the electrode;
(d) means for varying the electrode potential so as to cause the current to undergo at least part of a hysteresis cycle;
(e) means for calculating a characteristic point on the hysteresis curve from the recorded current measurements; and
(f) means for comparing the characteristic point with a stored value and for determining from this comparison whether the sensor meets a predetermined condition.
Such a device is adapted for use in the testing method according to the invention and the advantages of this testing method as set out above also apply in large part to the corresponding device, as well as to many of the preferred features set out below.
Thus, preferably, the characteristic point is a nodal point on the hysteresis curve, and the nodal point is preferably defined as a voltage for which the current value on the hysteresis curve is independent of the analyte concentration in the vicinity of the sensor when the sensor is functioning correctly.
The device preferably comprises a memory for storing the value of a characteristic point determined on an initial iteration of measurements of current values.
A further preferred feature is means for providing an alarm if it is determined that the sensor does not meet the predetermined condition.
The invention provides, in another aspect, a method for the in vivo measurement of an analyte, comprising:
(a) providing an in vivo sensor, which acts as an electrode of an electrical circuit, to a subject for measuring the analyte, wherein the operation of the sensor is dependent on a reaction in which oxygen is required;
(b) passing a voltage through the electrode, the voltage being of a magnitude and duration sufficient to cause the electrolysis of a chemical species present in the vicinity of the sensor so as to generate oxygen;
(c) measuring the signal produced by the sensor in response to the oxygen-dependent reaction; and
(d) repeating steps (b) and (c) periodically.
The use of electrolysis of a substance to generate oxygen can overcome the problems of a deficiency in oxygen inside the body, and thereby increase the accuracy of the sensor. It effectively raises the maximum level of analyte measurable where a lack of oxygen is the limiting factor in analyte measurement.
Preferably, water is the chemical species present in the vicinity of the sensor which is electrolysed to provide oxygen.
Preferably, step (b) continues for a duration sufficient to generate oxygen in an excess stoichiometric ratio relative to the analyte being measured at the sensor. Thus, if the measurement of analyte is achieved by a pulsatile sampling technique, oxygen generating pulses can be interleaved with the measurement pulses to ensure that at all times a sufficient amount of oxygen is present.
The invention also provides a device for the in vivo measurement of an analyte, comprising:
(a) an in vivo sensor for measuring the analyte and providing a signal in response to the measurement of the analyte, wherein the operation of the sensor is dependent on a reaction in which oxygen is required;
(c) an electrical circuit in which the sensor acts as an electrode, the electrical circuit comprising means for energising the electrode to a voltage which is of a magnitude and duration sufficient to cause the electrolysis of a chemical species present in the vicinity of the sensor to provide oxygen; and
(d) means for alternately generating oxygen by electrolysis and measuring the analyte by allowing the generated oxygen to take part in the reaction.
For any of the devices according to the invention, there may suitably be provided means for delivering a substance to the subject in response to the measured analyte values.
Thus, the device may comprise a pump containing insulin which may be pumped at a controllable rate in response to measured glucose levels. The principles of operation of such a pump will be known to the person skilled in the art, and suitable examples are disclosed in WO 96/14026, incorporated herein by reference.
Preferably the substance is a medicament suitable to correct a condition in the patient for which the analyte is an indicating agent.
The invention further provides a device for calibrating an analyte sensor in vivo, comprising:
(a) a sensor for application to a subject;
(b) means for providing a first predetermined stimulus to the sensor to produce a first sensor signal;
(c) means for measuring the first sensor signal; and
(d) means for determining a calibration function based on the first measured sensor signal resulting from the predetermined stimulus,
Preferably, the means for providing the first predetermined stimulus comprises a supply of material to which the sensor is sensitive, such that the material stimulates the sensor when the sensor is applied to a subject.
Further, preferably, the material is soluble in biological fluids present in the area of the subject to which the sensor is applied.
Suitably, the material comprises an analyte or a precursor or derivative thereof.
Preferably, the predetermined stimulus is adapted to saturate the sensor such that the first signal is a maximum signal.
In preferred embodiments, the device further comprises means for providing a second predetermined stimulus to the sensor so as to produce a second sensor signal and means for measuring the second sensor signal, such that the means for determination of the calibration function determines a calibration function based on the first and second measured sensor signals.
Preferably, the known points on a curve describing the measured performance of the sensor are endpoints of the curve.
The invention also provides a device for measuring an analyte in vivo comprising means for applying a sensor to a subject, means for calibrating the sensor according to the method of the present invention, and means for providing a calibrated output of any further measurements made by the sensor based on the calibration function.
FIG. 1A is a schematic diagram of an analyte monitor device according to the invention;
FIG. 1B is a schematic diagram of a display unit adapted for use with the monitor device of FIG. 1A;
FIG. 2 is a view of the underside of the monitor device of FIG. 1A;
FIG. 3 is an enlarged elevation of the sensor needle of the monitor device of FIG. 1A;
FIGS. 4A-4C are graphical representations of in vivo glucose levels in the vicinity of the sensor needle immediately after the monitor device of FIG. 1A is applied to a subject, the measured electrode current during the same period, and the applied electrode voltage during the same period, respectively;
FIG. 5 is a plot of electrode current versus analyte concentration for an analyte monitor device according to the invention in three different environments;
FIG. 6 is a plot of electrode current versus analyte concentration for an analyte monitor device according to the invention in two different environments;
FIG. 7 is a graphical representation of applied electrode voltage and measured electrode current for an analyte monitor device according to the invention;
FIG. 8 is a comparative plot of electrode current against glucose concentration illustrating the effect of generating oxygen in vivo using a method according to the invention;
FIGS. 9 and 10 each show a series of current-voltage hysteresis cycles measured at a number of different glucose concentrations using a method according to the invention, together with a current-voltage hysteresis cycle for the same sensor after sensor deterioration;
FIG. 11 is a plot of in vivo glucose concentration against time measured in tests carried out on a dog, comparing the results obtained using a device according to the invention as compared with standard reference tests;
FIG. 12 is a sectional elevation of an embodiment of a device according to the invention before final assembly by the user;
FIG. 13 is a sectional elevation of the device of FIG. 12 after final assembly;
FIG. 13A is an enlarged detail of the device of FIG. 13; and
FIG. 14 is an elevation of an alternative construction of sensor needle to that shown in FIG. 3.
FIG. 1A is a schematic illustration of an analyte monitor device for the in vivo measurement of an analyte according to the invention. FIG. 1B is a schematic illustration of a display unit, associated with the monitor device of FIG. 1A, for providing a visual output of the measured analyte levels.
The monitor device of FIG. 1A, indicated generally at 10, comprises a housing 11 separable into a first part 12 and a second part 13. The second part 13 of housing 11 has a lower surface 14 which is provided with a working electrode 15, a counter electrode 16 and a reference electrode 17. The device 10 is adhered to the skin of a subject by means of a conductive adhesive gel on the surfaces of counter electrode 16 and reference electrode 17.
Working electrode 15 is a platinum-iridium enzymatic sensor in the form of a needle the detailed structure of which will be described in detail below. Counter electrode 16 and reference electrode 17 are each in the form of a silver/silver chloride surface makes good electrical contact with the subject's skin by means of the adhesive gel thereon.
The electrodes 15,16,17 are connected to a microprocessor 18 via a voltage controller 19. Voltage controller 19 is adapted to supply constant voltages, pulsed voltages or varying voltages between the working electrode 15 and reference electrode 16. The voltage is controlled by the microprocessor 18, and both microprocessor 18 and voltage controller 19 are powered by a battery 20. A switch in the form of a push button 21 is used to stop or start the operation of the device, and an alarm 22 is provided to alert the user in the event of glucose levels being excessively high or low. The alarm 22 may also be used for a variety of other functions, such as to alert the user in the event of device malfunction or low battery levels, for example.
The monitor device 10 of FIG. 1A communicates with the display unit of FIG. 1B by means of a low power radio transmitter 23. The display unit of FIG. 1B, indicated generally at 24, is provided with a corresponding radio receiver 25, a visual LCD display 26, and a battery 27 to power the unit 24. Measured analyte levels from measuring device 10 can thus be transmitted to display unit 24.
FIG. 2 shows a view of the underside of monitor 10. Thus, lower surface 14 of second part 13 is seen with working electrode 15 (i.e. the enzymatic sensor needle) in the centre. On either side, the counter electrode 16 and reference electrode 17, respectively, are represented by two approximately semi-circular cross hatched areas. The lower surface 14 is provided with a suitable adhesive to hold device 10 securely in place against the subject's skin.
The enzymatic sensor needle 15 is shown in FIG. 3 in elevation. The platinum-iridium needle 15 has a plurality of apertures 28 which contain the enzyme glucose oxidase 29. The glucose oxidase enzyme 29 is thus recessed from the surface of the needle 15 in order to protect the enzyme 29 from being physically damaged, for example, when the needle 15 punctures the skin of a patient.
A protective membrane 30 is provided on the surface of the needle 15, with an external coating of glucose 31 which is used for the purpose of calibrating the needle in vivo, as will be described below.
Membrane 30 is glucose-permeable and oxygen-permeable, but it is more permeable to oxygen than to glucose. This selective permeability helps to ensure that oxygen is in excess of glucose for the purpose of ensuring that the rate of reaction is not limited by an insufficient oxygen supply. This problem is discussed in more detail below. Suitable membrane materials include polyurethane, Nafion (“Nafion” is a Trade Mark for a perflourinated ion-exchange membrane), cellulose materials or polysiloxanes.
An alternative construction to that discussed above (protective membrane coated with glucose) is provided in which the protective membrane is applied with soluble glucose particles embedded therein. Upon application to a subject, the glucose dissolves to leave pores in the membrane. The size and distribution of the glucose particles is chosen beforehand to ensure that the pores provide the selective permeability to oxygen discussed above.
In FIG. 3, two dimensions are shown, namely the length l of the needle 15 and the diameter d of the needle 15. Suitable dimensions are a needle length 26 of 5 mm and a needle diameter 27 of 0.3 mm, although it will be appreciated that a wide variety of dimensions can be employed as required.
The basic principle of operation of the monitor device 10 is as follows. The monitor device 10 (comprising reusable first part 12, which includes the electronic controlling circuitry, and disposable second part 13, which includes the enzymatic sensor needle 15) is applied to a subject by removing a release liner (not shown) which protects adhesive lower surface 14 and sensor needle 15 before use, and then pressing lower surface 14 against the skin of a subject so that sensor needle 15 penetrates the skin of the subject and enters the subcutaneous region where it is in contact with subcutaneous tissue. The silver/silver chloride electrodes 16 and 17 lie in contact with the skin of the subject by means of their adhesive conductive coatings. The display unit 24 is worn on the wrist of the subject or is located in some other suitable location (such as by a bedside or in a nurse's station to allow monitoring by third parties of a patient's condition).
In use, glucose in the blood, plasma or serum present in the subcutaneous region diff-uses through protective membrane 30 as do oxygen and water. The glucose (C6H12O6), oxygen (O2) and water (H2O) react in the presence of the glucose oxidase according to the reaction: thereby producing gluconic acid (C6H12O7) and hydrogen peroxide (H2O2) at the sensor needle 15. Accordingly, the rate of hydrogen peroxide generation at platinum-iridium needle 15 is theoretically proportional to the concentration of glucose in the bloodstream.
The hydrogen peroxide produced at the surface of the platinum-iridium needle is oxidised (the platinum acts as a catalyst) according to the reaction: Thus, the hydrogen peroxide serves as a source of electrons which are free to act as charge carriers if a potential is applied between the working electrode (sensor needle) 15 and the counter electrode 16.
The microprocessor 18 causes the voltage controller 19 to apply a voltage to the working electrode 15. The magnitude of the voltage is determined as a potential difference between the working electrode 15 and the reference electrode 17. However, no current flows between these two electrodes and instead the current flows through the counter electrode 16 (which is at the same potential as the reference electrode 17). In effect the circuit is a potentiostat, and the skilled person will be aware that this means that an accurate voltage can be applied to the working electrode relative to the counter-electrode, independent of the resistance between the electrodes, which might be expected to vary in individual cases.
Thus, when a voltage is applied to the working electrode 15, the microprocessor 18 measures the current flowing through the circuit of which the working electrode 15 and the counter electrode 16 form a part thereof. Since this current can only flow if free charge carriers are present, the current provides a measure of the number of charge carrying species in the vicinity of the working electrode 15. The majority of the current arises from the free electrons which are generated by the breakdown of hydrogen peroxide at the platinum (or platinum-iridium) needle surface.
As described in WO 96/14026, the voltage is only applied periodically between the working electrode 15 and the counter electrode 16. While the voltage between the working electrode and counter electrode is switched off, glucose reacts continuously with oxygen and water to generate increasing amounts of hydrogen peroxide at the sensor needle 15. By then applying a potential after it has been switched off for a given interval, all of the electrons generated by the hydrogen peroxide built up during the “off” interval are removed in a short burst of current which quickly decays to a steady state level, i.e. the level which would be detected if the voltage was applied continuously rather than intermittently.
By switching the voltage off and on repeatedly to allow a build up of hydrogen peroxide during the “off” interval and measuring accumulated hydrogen peroxide during the “on” interval, the measured contribution of charge carriers which arise from the breakdown of hydrogen peroxide is maximised relative to other charge carriers which might be present in the tissue of the user. Such other charge carriers give rise to a background level of current which is essentially constant over short periods of time.
The measured current is integrated by the microprocessor 18 to provide a measure of the total charge giving rise to the measured current: If Q represents the total charge of the combined charge carriers in a current flowing from 0 to t seconds, then:
∫0 tI.dt=Q
Thus, by integrating the current over the duration of the applied voltage, an uncalibrated measure of the glucose concentration in the bloodstream is provided. The integration of a current pulse will be discussed further below having regard to FIG. 7.
While this type of enzymatic sensor needle has been described in relation to glucose, the principles may also be applied to other enzymatic sensors for detecting analytes other than glucose.
3. In vivo calibration
The batch of sensor needles of which sensor needle 15 forms a part thereof will have been calibrated in the factory. This is most usually achieved by taking a statistically representative sample of needles from a production batch, carrying out a laboratory calibration (using a standard glucose solution, for example) and applying the results of this calibration for all of the needles in the batch (presuming that the batch appears to be of acceptable quality. The calibration of this batch can be encoded on second part 13 of the monitor device 10. Preferably, this is achieved by using a machine readable encoding system (such as a bar code or a simple chip containing the calibration parameters) which is automatically read by the microprocessor when the first part 12 and the second part 13 are connected together, or when start button 21 is actuated.
As discussed above, however, the sensor needle may have undergone some changes during storage, and thus the calibration function determined during a laboratory test may not be entirely accurate when a needle is in use in vivo. More importantly, the interface between the needle and the surrounding body tissue will always give rise to at least slight variations between the performance of otherwise identical sensor needles because of differences between individuals and between individual application sites on the same individual.
Therefore, a further calibration occurs in vivo as follows. When the needle 15 enters the body, the glucose coating 31 dissolves almost immediately and saturates the glucose oxidase enzyme 29. The microprocessor provides a voltage to the electrodes and measures the resulting current. Because the enzyme is saturated by glucose, this first measured signal is a saturated or maximum measurable signal.
FIGS. 4A-4C are three graphs illustrating: (FIG. 4A) the in vivo glucose level for an interval of time immediately after the sensor needle 15 has been applied to the body; (FIG. 4B) the measured electrode current over the same interval; and (FIG. 4C) the periodic voltage pulses (which are generated by the voltage controller 19 under the control of microprocessor 18) applied to the electrodes and which give rise to the measured current shown in FIG. 4B.
A voltage V1 (FIG. 4C) applied at time t1 gives a current I1 (FIG. 4B) which corresponds to the saturation level G1 (FIG. 4A) of the enzyme. Although the glucose level will be initially above level G1, the initial higher level is not shown as it is only the saturation level which can be measured by the sensor and which is of importance for the calibration method. Signal I1 is stored in the memory of the microprocessor 18 as a first sensor signal.
Subsequent pulses V2, V3, V4, etc. give rise to progressively lower signals I2, I3, I4, etc. as the glucose diffuses away from the sensor needle 15 and is consumed in reaction with oxygen and water. The microprocessor 18 monitors the lowering signals until signals I7 and I8 are observed to be substantially equal. This indicates that glucose level G2 is the equilibrium glucose level, i.e. the concentration of glucose in the subcutaneous tissue of the patient at this time.
At this point, a prolonged pulse V9 is applied which consumes all of the charge carriers at the sensor needle 15 due to hydrogen peroxide breakdown, i.e. giving a current signal I9 which drops from a measure of the equilibrium glucose level G2 to a measure of the background charge carrier level G3 which is due to extraneous influences. Signal I9 is also recorded by the microprocessor for calibration purposes.
After recording the first sensor calibration signal I1 and the second sensor calibration signal I9 the microprocessor resumes the intermittent pulsing V10, V11, etc.
The scale and number of individual pulses in FIG. 7 relative to the overall timescale is not accurate, since a period of 5-10 minutes might typically be expected for the dissolution of glucose and its subsequent elimination by diffusion and enzymatic breakdown. During this time, a large number of pulses of short duration would be measured in practice.
When the first and second calibration signals I1 and I9 have been measured, the calibration function for this particular sensor needle 15 in this particular environment is calculated, and this can be explained with reference to FIG. 5.
FIG. 5 shows a plot of the characteristic performance curves of three different sensor needles from the same batch. The graph shows the signal measured in the case of each needle at different analyte concentrations:
Curve 40 is the theoretical or laboratory-calibrated performance curve measured in the manufacturing facility for the batch of sensor needles. This curve is the mean calibration curve for the batch of needles, measured from tests carried out on a statistically valid sample.
Curve 41 is the measured performance curve of a first sensor needle in vivo and curve 42 is the measured performance curve of a second sensor needle in vivo.
It will be seen that for each curve 40,41,42 there is a well-defined increase in signal strength for increasing analyte concentration. However, at a certain point the needle becomes saturated, and beyond this point, the signal strength does not increase with increasing analyte concentration.
The in vivo needle represented by curve 41 is calibrated as follows: shortly after it is applied to the subject, a maximum sensor signal 41 a is measured as described above (I1). The amount of glucose provided on the sensor needle is sufficient to ensure that this signal will lie in the saturation region. As further described above, periodic pulses are then applied to the needle and this causes substantially all of the excess glucose in the vicinity of the needle to be consumed until the equilibrium glucose level G2 is reached, following which a prolonged voltage pulse causes the glucose concentration to drop to a base line level (G3). At this point the second sensor signal 41 b is measured as described above (I9).
The microprocessor compares each of these signals 41 a, 41 b with the corresponding signals on the theoretical or laboratory-measured signal-concentration curve 40 i.e. signal 41 a is compared with signal 40 a and signal 41 b is compared with signal 40 b. Since it is known that the calibration curves for needles from the same batch will all have the same basic shape, the calibration curve 41 for the in vivo sensor needle can be mapped onto the theoretical calibration curve 40 by mapping two known points on curve 41 to two known points on curve 40. In the case of both curves, the saturated signal value and the base line signal value has been measured, so a calibration function mapping any intermediate point from curve 41 onto curve 40 is easily derived.
Since the calibration parameters are encoded in the factory on the second part of the device, instructions are already provided for the microprocessor to calculate a calibrated output for any given point on the theoretical (laboratory measured) curve 40. The calculation of a calibration function mapping curve 41 onto curve 40 provides complete information for the microprocessor to provide a calibrated output for any subsequent measured signal which lies on curve 41.
In the case of curve 41, the calibration function involves increasing all signals by an amount corresponding to the constant vertical distance between curves 40 and 41. Thus, when a signal 41 c is measured, the microprocessor calculates the corresponding point 40 c and provides, as an output which is transmitted to the display unit, the calibrated measurement corresponding to point 40 c which can then be displayed in meaningful units.
The same basic principles apply to the calibration of the individual sensor needle which has characteristic measured curve 42. However, the calibration function must take into account the fact that the difference between the saturation signals 40 a, 42 a is considerably less than the difference between the base line signals 40 b, 42 b. Thus, in order to map a measured point 42 c onto the corresponding point 40 c on theoretical curve 40, the microprocessor must apply a concentration-dependent calibration function in which the amount added to (or subtracted from) the measured signal 42 c, when mapping this signal to point 40 c, varies in accordance with the position of this point along curve 42 c. Nevertheless, it will be appreciated that the similarity in basic shape between all three curves 40,41,42 makes the mapping of any measured curve to the theoretical curve a relatively simple operation, in which it is possible to deduce the mapping of the entire curve from a small number of measurements.
In certain cases it may be possible to use only one measurement. For example, if all sensors in a batch must provide a zero output whenever there is a zero level of analyte (no background signal), then a regular curve can be mapped onto the theoretical curve from only one measured point. Conversely, it may be desirable to employ three or more measurements in the calibration if sufficient accuracy cannot be obtained using two points.
The above-described calibration method enables expected variations in sensor behaviour to be compensated for. If the measurements are outside a given range (e.g. �30% of the laboratory measured values) the microprocessor may be programmed to sound an alarm to indicate that the sensor is apparently defective and should not be used.
FIG. 6 shows an example of the results of the calibration process achieved in an experimental trial. A calibrated reference curve 45 (obtained by calibration of the sensor needle in vitro) is shown, with end points 45 a (saturation) and 45 b (base line) as shown. A measured curve 46 is extrapolated by measuring saturation and base line end points 46 a, 46 b, respectively. From these measurements it is determined that the measured (in vivo) curve lies a constant 0.03 mA below the reference (laboratory calibrated) curve. Thus, a subsequent measurement 46 c of 0.38 mA can then be correlated to a value of 0.41 mA on the reference curve, which in turn corresponds to a glucose concentration of 4 mM (72 mg/dlit).
It should be noted that the glucose concentration is shown on a logarithmic scale in which each equal step along the scale represents a doubling of glucose concentration. For this reason, it can be seen that the calibration function is extremely important, since a reading of 0.38 mA would otherwise be interpreted (from the reference curve) as relating to a glucose concentration of only slightly more than 3 mM.
4. In vivo Oxygen Generation
As can be seen from the chemical equation for the glucose/oxygen/water reaction set out above, the correct operation of the sensor presupposes that all of the glucose present in the vicinity of the glucose oxidase will react (at least up to the point where the sensor needle is saturated). The rate of reaction is, in theory, limited by the amount of glucose (and thus this reaction can be used to measure glucose). However, if in practice there is a lack of oxygen, then oxygen may become the limiting factor in the reaction, rather than glucose. The result of this is that the current level will provide an indication of the amount of oxygen rather than the amount of glucose.
A solution to this problem is illustrated in FIG. 7, in which the voltage is provided in two repeating series of pulses, namely a series of current measurement pulses 50 and a series of oxygen-generating pulses 51.
The series of current measurement pulses 50 of 0.6 V is used to measure current resulting from the hydrogen peroxide breakdown. The microprocessor measures the resulting electrode current 53 when these 0.6 V pulses are applied, and integrates the measured current 53 over the duration of the pulse to obtain a measurement of the charge carriers involved in the current pulse. As previously explained, the number of charge carriers is primarily determined by the amount of hydrogen peroxide generated by the reaction of glucose with oxygen and water. Each current pulse 53 is shown with a shaded area 54 which represents the additional current obtained by allowing the hydrogen peroxide to build up using a pulsatile measurement mode. The blank area 55 below shaded area 54 corresponds to the steady state current which would be obtained if there was no pulsatile measurement but instead there was a steady state measuring voltage.
In addition to the current measurement pulses 50, the series of oxygen-generating pulses 51 of 1.3 V is provided such that each 1.3 V pulse 51 immediately follows after a current measurement pulse 50. These oxygen-generating pulses 51 of 1.3 V serve to generate oxygen by electrolytically breaking down water. This generates a sufficient amount of oxygen to ensure that oxygen is in excess of glucose in the vicinity of the sensor needle, and it therefore follows that glucose is the limiting factor in the measurement process, ensuring an accurate measurement of glucose.
During the period when the oxygen generating pulse 51 is being applied across the electrodes, there will be a measurable electrode current which is not shown on the graph for purposes of clarity.
Following the generation of oxygen by an oxygen-generating pulse 51, the voltage is switched off for a period 52 of time to allow the glucose to react with the oxygen in the presence of glucose oxidase and produce hydrogen peroxide. The hydrogen peroxide breaks down at the needle 15 and when the current is switched on there is a current surge (as shown in the top half of the graph) which falls away to a base line level.
The time periods indicated in FIG. 7 are not shown to scale. Representative times for the current measurement pulses 50 are preferably 0.01s-1.0s, most preferably approximately 0.1s; for the oxygen-generating pulses 51 the time is also preferably 0.0s-1.0s, most preferably approximately 0.1s; and for the accumulation period 52 between the end of an oxygen-generating pulse 51 and the next current measurement pulse 50, the gap is preferably 0.05s-10s, most preferably approximately 1.0s. These times are given for reference purposes only, and depending on the particular circumstances, times lying outside these ranges may be suitable.
FIG. 8 shows the results of using a series of oxygen-generating pulse as described above. Curve 60 shows the average electrode current generated by a sensor such as sensor needle 15 at increasing glucose concentrations up to 16 mM. Curve 61 shows the current generated when an oxygen-generating pulse is included in the cycle. It can be seen that this causes a dramatic increase in the maximum level of current obtainable, as well as in the current range corresponding to the range of glucose concentrations illustrated. The advantage of having a larger current range is that a more accurate measurement of the glucose concentration becomes possible.
5. In vivo Testing of Sensor
As previously stated, the invention encompasses a method for the in vivo testing of an analyte sensor which is provided to a subject as an electrode of an electrical circuit. FIG. 9 illustrates how this method operates.
In FIG. 9, five current-voltage (I-V) characteristic curves are plotted. The curves show the current response to a cyclically varying voltage. The voltage is varied in each case through a cycle from 0.0 V to 0.58 V.
These cycles were measured in vitro using a sensor needle 15 as shown in FIG. 3. To simulate the in vivo situation in which the glucose level will fall from a saturation level to a background level, the current-voltage measurements were repeated at progressively lower concentrations, i.e. from an initial saturation level to a background level to obtain the I-V characteristics shown in FIG. 9. Curves 70, 71, 72 and 73 respectively are measured at levels of 9�10−5 (units?), 6�10−5 (units?), 3�10−5 (units?), and zero (background level), respectively. Each voltage cycle took 20 s and in practice one might measure a hysteresis cycle 1-2 minutes for 5-15 minutes after application of the device to obtain hysteresis cycles corresponding to a range of glucose concentrations.
As can be seen, each of the I-V characteristic curves 70-73 exhibits hysteresis, i.e. the current values for the increasing voltage part of the each I-V curve are different to the current values for the decreasing voltage part of each curve. For example, the current measured at 0.4 V for the background level curve 73 has two different values. When the voltage is being increased from 0 V to 0.58 V, the current measured at 0.4 V is approximately −0.25 mA (denoted at 73 a). After the voltage has reached 0.58 V and is decreased down to 0 V, it again passes through the level of 0.4 V, but a different current is measured, namely +0.5 mA (denoted at 73 b).
As one would expect, different I-V characteristics are measured at different glucose concentrations. At two distinct nodal points, however, the four measured I-V curves 70-73 intersect: at a voltage of 0.26 V on the increasing part of each of the curves 70-73 (nodal point denoted at 74), the measured current level is −0.4 mA for all concentrations of glucose; and at a voltage of 0.12 V on the decreasing part of each of the curves 70-73 (nodal point denoted at 75), the measured current level is +0.35 mA for all concentrations of glucose.
Curve 76 is the I-V characteristic for the same needle after it has deteriorated somewhat. The most normal reason for needle deterioration in vivo is that the surface of the needle becomes coated with protein such as fibrin by the body. Any coating on the surface of the needle may adversely affect the reliability of the sensor needle, and so deterioration of the sensor needle used in the measurement of curves 70-73 has been simulated by the addition of a light coating of cellulose acetate. The needle is then reinserted into the subject and the cyclical I-V measurement is repeated to give curve 76.
The effect of this coating is that the shape of curve 76 is distorted such that it does not pass through the nodal points 74,75. While curve 76 passes close to nodal point 74, it is clearly far removed from nodal point 75, i.e. at a (decreasing) voltage of 0.12 V, the current level is approximately 1 mA whereas one would expect that the current level, irrespective of the glucose concentration, would be 0.35 mA.
In use, the microprocessor calculates a series of I-V curves 70-73 as the glucose level falls from the saturation level to the background level, and by comparing these curves, obtains and stores a value for one or more nodal points 74,75 at which the glucose level has no effect on the current-voltage response for a correctly functioning sensor.
Periodically thereafter (e.g. every 30 minutes or every hour), the microprocessor repeats the cyclical electrode voltage variation, and measures the current response. The current values at the voltages where nodal points were previously measured are then compared to the expected values, and any significant deviation indicates a deterioration in the functioning of the microprocessor.
Depending on the degree of accuracy required, the microprocessor may be programmed to sound an alarm if the measured current differs from the expected nodal point value by e.g. 10% or more. Thus, the user will be alerted in good time if the sensor needle requires replacement.
FIG. 10 shows a repetition of the measurements illustrated in FIG. 9, with curves 80, 81, 82 and 83 being I-V curves measured as the glucose concentration drops from a saturation level to a base line level. Nodal points 84 and 85 are easily identifiable. However, in this case instead of applying a coating of cellulose acetate, a coating of polyvinyl pyrrolidone (PVP) was used, and the resulting I-V curve 86 is plotted.
The effect of a PVP coating is more subtle than that of a cellulose acetate coating, in that curve 86 passes directly through nodal point 85. Nevertheless, curve 86 clearly does not pass through nodal point 84, and a difference of at least 0.1 mA can be measured, indicating the presence of the coating.
FIG. 11 shows measurement results achieved with a glucose monitor according to the invention when compared to a reference average. Along the bottom of the graph are a series of black squares which indicate points at which insulin was delivered in an in vivo test on dogs. Open triangles indicate points at which glucose was delivered. The line joining the small diamonds shows the glucose concentration in mg/dlit and the line joining the large squares indicates the corresponding measurements made using electrodes according to the invention.
The reference line (small diamonds) is obtained from an average of four conventional glucose measurement tests, namely two analyses conducted by independent veterinary or medical laboratories, and two commercially available glucose testing kits (“Medisense” and “Elite”). The line denoting glucose monitors according to the invention was obtained from an average of three electrodes of the type illustrated in FIG. 3. It can be seen from these results that glucose monitors according to the invention closely mimic conventional methods of monitoring glucose levels.
The slight differences between the lines for the sensors according to the invention and the reference measurements can be explained by the fact that the reference line was obtained from the average of four tests using fresh whole blood samples from the cardiovascular system whereas the sensor according to the present invention was monitoring the glucose levels in subcutaneous tissue. Accordingly, while one expects to see an almost immediate increase in glucose levels in the intravenous system after glucose is administered intravenously, one expects to see a delay when the glucose measurement is made subcutaneously. Furthermore, one expects the sharp peaks and troughs measurable in blood samples to be smoothed out or averaged slightly in subcutaneous tissue because of the delay involved in blood diffusing into such tissue.
FIG. 12 shows a schematic illustration of a needle deployment mechanism which can be used for an analyte monitor according to the invention. The embodiment of FIG. 12 is based on the embodiment discussed above in relation to FIGS. 1-3, and like parts are denoted by like reference numerals. Thus, the device 10 includes a first part 12 and a second part 13. Second part 13 has a lower surface 14 on which a reference electrode 16 and a counter electrode 17 are situated. A deployment mechanism, indicated generally at 90, carries sensor needle 15 which acts as a working electrode. Deployment mechanism 90 comprises a generally cylindrical casing 91 extending from second part 13. A platform 92 is movably mounted in casing 90, platform 92 carrying needle 15 on the underside thereof. Lower surface 14 of second part 13 is provided with an aperture 93 through which needle 15 can extend when platform 92 is caused to move downwards to the position shown in FIG. 13.
As can be seen from FIG. 13, first part 12 of device 10 can be mated with second part 13 by means of an annular recess 94 in second part 13 which received cylindrical casing 91. Annular recess 94 defines a cylindrical projection 95 in the centre thereof. Cylindrical projection 95 causes platform 92 to be pushed downwards within cylindrical casing 91 when first part 12 is mated to second part 13. A spring 96 which biases platform 92 upwards resists the mating of first part 12 to second part 13, but a snap-fit mechanism defined by a lip 97 (see also FIG. 13A) on first part 12 and a groove 98 on second part 13, groove 98 corresponding to lip 97 such that lip 97 is retained within groove 98 when first part 12 is mated to second part 13 as shown in FIG. 13A.
The first part 12 and second part 13 are each provided with the requisite electrical connections (not shown) to connect the electrodes 15-17 to the electronic controlling circuitry provided in second part 13. Thus, the second part 13 can be a reusable electronic controller module and first part 12 can be a disposable electrode module. In order to replace the disposable electrode module which the first part 12 constitutes, a release button 99 is provided on the second part 13. FIG. 13A shows a detail of the device 10 in which a lip 97, groove 98 and release button 99 can be seen more clearly. The release button 99 is provided with a sloped surface 100 such that when the release button 99 is pushed towards the right, the sloped surface 100 exerts a downward force on the first part 12 to release the lip 97 from the groove 98. This allows the first part 12 to disengage from the second part 13, the disengagement being assisted by the spring 96 which tends to bias the platform 92 away from the lower surface 14.
The second part 13 can be provided with means for displaying the measured analyte level and/or with alarm means for indicating that the analyte level has passed beyond a pre-programmed limit. As an alternative to display means, the controller can be provided with a transmitter which transmits a suitable signal to a remote receiver which is provided with a display. This allows the monitor to warn the user discreetly, with the display being readable from a wristwatch-type display unit.
FIG. 14 shows an alternative construction of a sensor needle, indicated generally at 110, in which the platinum-iridium needle of FIG. 3 is replaced by a stainless steel needle shaft 111 on which a coating of platinum black 112 (otherwise referred to as colloidal platinum) is provided, with glucose oxidase enzyme embedded in the platinum black coating 112. This platinum black coating is coated by a protective polyurethane membrane 113 and this in turn is provided with a soluble glucose coating 114. The operation of the sensor needle 110 is essentially identical to that of the sensor needle 15 of FIG. 3, i.e. glucose reacts with oxygen and water in the presence of the enzyme embedded in the platinum black coating 112, thereby producing hydrogen peroxide which is catalysed by the colloidal platinum to provide free electrons.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS2408323Jun 10, 1943Sep 24, 1946Margaret L LockhartHypodermic syringeUS2576951Sep 29, 1950Dec 4, 1951Compule CorpHypodermic syringe assemblies, including plural-compartment admixing ampoules for segregated storage of ingredients of liquid mediginal solutions and parts thereofUS3964482May 17, 1971Jun 22, 1976Alza CorporationDrug delivery deviceUS4340458Jun 2, 1980Jul 20, 1982Joslin Diabetes Center, Inc.Glucose sensorUS4396464Apr 22, 1982Aug 2, 1983Joslin Diabetes Center, Inc.Method for sensing the concentration of glucose in biological fluidsUS4515584Jun 29, 1983May 7, 1985Fujisawa Pharmaceutical Co., Ltd.Artificial pancreasUS4627445Apr 8, 1985Dec 9, 1986Garid, Inc.Glucose medical monitoring systemUS4637403Jun 14, 1985Jan 20, 1987Garid, Inc.Glucose medical monitoring systemUS4684365Oct 10, 1985Aug 4, 1987Eaton CorporationDisposable refill unit for implanted medication infusion deviceUS4684367Apr 12, 1985Aug 4, 1987Meditec Research AssociatesAmbulatory intravenous delivery systemUS4697622Jun 13, 1986Oct 6, 1987Parker Hannifin CorporationPassive filling deviceUS4805624Apr 14, 1987Feb 21, 1989The Montefiore Hospital Association Of Western PaLow-potential electrochemical redox sensorsUS4886499Dec 4, 1987Dec 12, 1989Hoffmann-La Roche Inc.Portable injection applianceUS4902278Feb 18, 1987Feb 20, 1990Ivac CorporationFluid delivery micropumpUS4953552Apr 21, 1989Sep 4, 1990Demarzo Arthur PBlood glucose monitoring systemUS4970145Jan 20, 1988Nov 13, 1990Cambridge Life Sciences PlcImmobilized enzyme electrodesUS5070886Jun 19, 1990Dec 10, 1991Safety Diagnostice, Inc.Blood collection and testing meansUS5079421Dec 4, 1990Jan 7, 1992Inomet, Inc.Invasive FTIR blood constituent testingUS5090963Oct 19, 1990Feb 25, 1992Product Development (Z.G.S.) Ltd.Electrochemically driven metering medicament dispenserUS5122456Apr 29, 1988Jun 16, 1992Cambridge Life Science PlcAmperometric method for the quantitative determination of 1,4-dihydronicotinamide adenine dinucleotide (nadh) in solutionUS5160418Jul 18, 1989Nov 3, 1992Cambridge Life Sciences PlcEnzyme electrodes and improvements in the manufacture thereofUS5165407Apr 9, 1991Nov 24, 1992The University Of KansasImplantable glucose sensorUS5193545Feb 7, 1990Mar 16, 1993Avl Medical Instruments AgDevice for determining at least one medical variableUS5231028Oct 19, 1988Jul 27, 1993Cambridge Life Sciences PlcImmobilized enzyme electrodesUS5242406Dec 16, 1991Sep 7, 1993Sil Medics Ltd.Liquid delivery device particularly useful for delivering drugsUS5267152 *Oct 26, 1990Nov 30, 1993Yang Won SNon-invasive method and apparatus for measuring blood glucose concentrationUS5286362Apr 27, 1993Feb 15, 1994Boehringer Mannheim GmbhMethod and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds thereforUS5298022Jan 4, 1993Mar 29, 1994Amplifon SpaWearable artificial pancreasUS5322063Oct 4, 1991Jun 21, 1994Eli Lilly And CompanyHydrophilic polyurethane membranes for electrochemical glucose sensorsUS5387328Apr 15, 1993Feb 7, 1995Sensor Technology Research Center Of Kyungpook National UniversityBio-sensor using ion sensitive field effect transistor with platinum electrodeUS5399245Sep 3, 1993Mar 21, 1995North Carolina State UniversityMethods of indirect electrochemistry using ionomer coated electrodesUS5422246Dec 13, 1991Jun 6, 1995Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek TnoElectrode having a polymer coating with a redox enzyme bound thereto, the polymer coating being formed on the walls of pores extending through a porous membraneUS5425361Nov 30, 1992Jun 20, 1995Paul-Gerhard FenzleinApparatus for the determination of medical, electro-chemical measured values relevant to organic or metabolic functionsUS5443701Aug 23, 1993Aug 22, 1995Yissum Research Development Company Of Hebrew University Of JerusalemElectrobiochemical analytical method and electrodesUS5497772Nov 19, 1993Mar 12, 1996Alfred E. Mann Foundation For Scientific ResearchGlucose monitoring systemUS5515848Jun 7, 1995May 14, 1996Pi Medical CorporationImplantable microelectrodeUS5527288Jan 18, 1994Jun 18, 1996Elan Medical Technologies LimitedIntradermal drug delivery device and method for intradermal delivery of drugsUS5543024Sep 25, 1990Aug 6, 1996Mitsubishi Denki Kabushiki KaishaGlucose sensitive FET sensor and method of making sameUS5545143Jan 7, 1994Aug 13, 1996T. S. I. MedicalDevice for subcutaneous medication deliveryUS5547467Jul 23, 1993Aug 20, 1996Massachusettes Institute Of TechnologyMethod for rapid temporal control of molecular transport across tissueUS5562613Jul 6, 1994Oct 8, 1996Intermed, Inc.Subcutaneous drug delivery deviceUS5567290Jul 23, 1993Oct 22, 1996The Victoria University Of ManchesterSensor devicesUS5569186Apr 25, 1994Oct 29, 1996Minimed Inc.Closed loop infusion pump system with removable glucose sensorUS5697366 *Jan 27, 1995Dec 16, 1997Optical Sensors IncorporatedIn situ calibration system for sensors located in a physiologic lineUS5976085 *Oct 7, 1997Nov 2, 1999Optical Sensors IncorporatedIn situ calibration system for sensors located in a physiologic lineDE4221848A1Jul 3, 1992Jan 5, 1994Eckard Dr SalzsiederAutomatic in situ calibration of in vivo glucose sensors - by comparing measured value with reference signal from independent model, calculating quality control values and correcting sensor signal if these exceed specified limitsEP0098592A2Jul 5, 1983Jan 18, 1984Fujisawa Pharmaceutical Co., Ltd.Portable artificial pancreasEP0209677A1May 27, 1986Jan 28, 1987Ivac CorporationElectrochemically-driven pulsatile drug dispenserEP0396788A1May 8, 1989Nov 14, 1990Dr�ger Nederland B.V.Process and sensor for measuring the glucose content of glucosecontaining fluidsEP0401179A1May 28, 1990Dec 5, 1990AMPLIFON S.p.A.Wearable artificial pancreasWO1994013203A1Dec 10, 1993Jun 23, 1994Novo Nordisk A/SMethod and apparatus for in vivo determination of the concentration in a body fluid of metabolically significant substancesWO1995010223A2Oct 12, 1994Apr 20, 1995Inomet, Inc.Interstitial fluid collection and constituent measurementWO1995013838A1Nov 17, 1994May 26, 1995Elan Medical Technologies LimitedIntradermal drug delivery deviceWO1995025089A1Mar 17, 1995Sep 21, 1995Ihara Chemical Industry Co., Ltd.Processes for producing thioaryl compoundWO1996006019A1Jun 12, 1995Feb 29, 1996Riverwood International CorporationCarrier with bottom panel lockWO1996025088A1Feb 8, 1996Aug 22, 1996Minimed Inc.Transcutaneous sensor insertion set* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS6560471 *Jan 2, 2001May 6, 2003Therasense, Inc.Analyte monitoring device and methods of useUS6830551 *Nov 8, 2000Dec 14, 2004Arkray, Inc.Body fluid measuring instrument and body fluid sampler thereofUS6931327 *Aug 1, 2003Aug 16, 2005Dexcom, Inc.System and methods for processing analyte sensor dataUS7258673Aug 28, 2003Aug 21, 2007Lifescan, IncDevices, systems and methods for extracting bodily fluid and monitoring an analyte thereinUS7295867Feb 12, 2003Nov 13, 2007Animas CorporationSignal processing for measurement of physiological analytesUS7299082 *Oct 27, 2004Nov 20, 2007Abbott Diabetes Care, Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS7310544 *Mar 10, 2005Dec 18, 2007Dexcom, Inc.Methods and systems for inserting a transcutaneous analyte sensorUS7384397 *Dec 30, 2003Jun 10, 2008Medtronic Minimed, Inc.System and method for sensor recalibrationUS7426408 *Aug 2, 2004Sep 16, 2008Becton, Dickinson And CompanyMinimally-invasive system and method for monitoring analyte levelsUS7455663Dec 26, 2006Nov 25, 2008Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS7455760 *Feb 2, 2005Nov 25, 2008Instrumentation Laboratory CompanyAnalytical instruments, biosensors and methods thereofUS7519408Nov 17, 2004Apr 14, 2009Dexcom, Inc.Integrated receiver for continuous analyte sensorUS7519409Dec 29, 2005Apr 14, 2009Medtronic, Inc.Implantable cell/tissue-based biosensing deviceUS7569050Aug 23, 2005Aug 4, 2009Medtronic Minimed, Inc.Infusion device and method with drive device in infusion device and method with drive device in separable durable housing portionUS7615007 *Mar 26, 2007Nov 10, 2009Dexcom, Inc.Analyte sensorUS7641649Aug 23, 2005Jan 5, 2010Medtronic Minimed, Inc.Reservoir support and method for infusion deviceUS7653425Jan 26, 2010Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring systemUS7654956Feb 2, 2010Dexcom, Inc.Transcutaneous analyte sensorUS7657297 *Feb 2, 2010Dexcom, Inc.Implantable analyte sensorUS7682338Mar 23, 2010Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS7686787Aug 23, 2005Mar 30, 2010Medtronic Minimed, Inc.Infusion device and method with disposable portionUS7697967Sep 28, 2006Apr 13, 2010Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertionUS7699833Aug 23, 2005Apr 20, 2010Moberg Sheldon BPump assembly and method for infusion deviceUS7711402Dec 22, 2004May 4, 2010Dexcom, Inc.Device and method for determining analyte levelsUS7713574Mar 10, 2005May 11, 2010Dexcom, Inc.Transcutaneous analyte sensorUS7715893Dec 3, 2004May 11, 2010Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS7731657Aug 30, 2005Jun 8, 2010Abbott Diabetes Care Inc.Analyte sensor introducer and methods of useUS7736310Jan 30, 2006Jun 15, 2010Abbott Diabetes Care Inc.On-body medical device securementUS7736338Dec 26, 2006Jun 15, 2010Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS7736344Nov 22, 2006Jun 15, 2010Medtronic Minimed, Inc.Infusion medium delivery device and method with drive device for driving plunger in reservoirUS7744589Jun 29, 2010Medtronic Minimed, Inc.Infusion medium delivery device and method with drive device for driving plunger in reservoirUS7761130Jul 20, 2010Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS7766829Nov 4, 2005Aug 3, 2010Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systemsUS7768386Jul 31, 2007Aug 3, 2010Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS7768387Apr 14, 2008Aug 3, 2010Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS7771352May 1, 2008Aug 10, 2010Dexcom, Inc.Low oxygen in vivo analyte sensorUS7774145Aug 10, 2010Dexcom, Inc.Transcutaneous analyte sensorUS7775975Aug 17, 2010Dexcom, Inc.Analyte sensorUS7778680Aug 17, 2010Dexcom, Inc.System and methods for processing analyte sensor dataUS7783333Mar 10, 2005Aug 24, 2010Dexcom, Inc.Transcutaneous medical device with variable stiffnessUS7788047Apr 27, 2007Aug 31, 2010Sencal LlcDisposable, pre-calibrated, pre-validated sensors for use in bio-processing applicationsUS7789857Dec 26, 2006Sep 7, 2010Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS7792562Sep 7, 2010Dexcom, Inc.Device and method for determining analyte levelsUS7794434Nov 20, 2006Sep 14, 2010Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS7797028Sep 14, 2010Dexcom, Inc.System and methods for processing analyte sensor dataUS7801582Mar 31, 2006Sep 21, 2010Abbott Diabetes Care Inc.Analyte monitoring and management system and methods thereforUS7811231Oct 12, 2010Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of useUS7811262Nov 20, 2006Oct 12, 2010Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS7822455Oct 26, 2010Abbott Diabetes Care Inc.Analyte sensors and methods of useUS7826382Nov 2, 2010Abbott Diabetes Care Inc.Close proximity communication device and methodsUS7826879Feb 28, 2006Nov 2, 2010Abbott Diabetes Care Inc.Analyte sensors and methods of useUS7826981Nov 2, 2010Dexcom, Inc.System and methods for processing analyte sensor dataUS7828728Feb 14, 2007Nov 9, 2010Dexcom, Inc.Analyte sensorUS7828764Nov 20, 2006Nov 9, 2010Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS7831287Nov 9, 2010Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS7835777Nov 16, 2010Dexcom, Inc.Device and method for determining analyte levelsUS7857506Dec 5, 2005Dec 28, 2010Sencal LlcDisposable, pre-calibrated, pre-validated sensors for use in bio-processing applicationsUS7857760Feb 22, 2006Dec 28, 2010Dexcom, Inc.Analyte sensorUS7860544Mar 7, 2007Dec 28, 2010Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS7860545Feb 26, 2008Dec 28, 2010Dexcom, Inc.Analyte measuring deviceUS7869853Jan 11, 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS7875047Jan 25, 2007Jan 25, 2011Pelikan Technologies, Inc.Method and apparatus for a multi-use body fluid sampling device with sterility barrier releaseUS7875293May 10, 2004Jan 25, 2011Dexcom, Inc.Biointerface membranes incorporating bioactive agentsUS7881763May 2, 2006Feb 1, 2011Dexcom, Inc.Optimized sensor geometry for an implantable glucose sensorUS7883464Sep 30, 2005Feb 8, 2011Abbott Diabetes Care Inc.Integrated transmitter unit and sensor introducer mechanism and methods of useUS7885697 *Feb 8, 2011Dexcom, Inc.Transcutaneous analyte sensorUS7885698Feb 28, 2006Feb 8, 2011Abbott Diabetes Care Inc.Method and system for providing continuous calibration of implantable analyte sensorsUS7885699Feb 8, 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS7892183Feb 22, 2011Pelikan Technologies, Inc.Method and apparatus for body fluid sampling and analyte sensingUS7896809Nov 3, 2008Mar 1, 2011Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS7899511Jan 17, 2006Mar 1, 2011Dexcom, Inc.Low oxygen in vivo analyte sensorUS7901354May 1, 2008Mar 8, 2011Dexcom, Inc.Low oxygen in vivo analyte sensorUS7901365Mar 8, 2011Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS7905833 *Jun 21, 2005Mar 15, 2011Dexcom, Inc.Transcutaneous analyte sensorUS7905868Oct 27, 2006Mar 15, 2011Medtronic Minimed, Inc.Infusion medium delivery device and method with drive device for driving plunger in reservoirUS7909774Mar 22, 2011Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS7909775Mar 22, 2011Pelikan Technologies, Inc.Method and apparatus for lancet launching device integrated onto a blood-sampling cartridgeUS7909777Sep 29, 2006Mar 22, 2011Pelikan Technologies, IncMethod and apparatus for penetrating tissueUS7909778Apr 20, 2007Mar 22, 2011Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS7914450Mar 29, 2011Dexcom, Inc.System and methods for processing analyte sensor dataUS7914465Feb 8, 2007Mar 29, 2011Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS7917186Mar 29, 2011Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS7920906Mar 9, 2006Apr 5, 2011Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibrationUS7920907Jun 7, 2007Apr 5, 2011Abbott Diabetes Care Inc.Analyte monitoring system and methodUS7925321Mar 23, 2010Apr 12, 2011Dexcom, Inc.System and methods for processing analyte sensor dataUS7927010Apr 19, 2011SenCal, LLCDisposable, pre-calibrated, pre-validated sensors for use in bio-processing applicationsUS7927274Apr 19, 2011Dexcom, Inc.Integrated receiver for continuous analyte sensorUS7928850Apr 19, 2011Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS7933639Apr 26, 2011Dexcom, Inc.System and methods for processing analyte sensor dataUS7935057May 3, 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS7935085Jan 28, 2010May 3, 2011Medtronic Minimed, Inc.Infusion device and method with disposable portionUS7938787May 10, 2011Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS7946984May 24, 2011Dexcom, Inc.Transcutaneous analyte sensorUS7948369Aug 2, 2010May 24, 2011Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS7949381Apr 11, 2008May 24, 2011Dexcom, Inc.Transcutaneous analyte sensorUS7949382Jul 27, 2010May 24, 2011Arkal Medical, Inc.Devices, systems, methods and tools for continuous glucose monitoringUS7951080May 31, 2011Abbott Diabetes Care Inc.On-body medical device securementUS7955261Mar 23, 2010Jun 7, 2011Dexcom, Inc.System and methods for processing analyte sensor dataUS7955305Aug 23, 2005Jun 7, 2011Medtronic Minimed, Inc.Needle inserter and method for infusion deviceUS7959569Mar 23, 2010Jun 14, 2011Dexcom, Inc.System and methods for processing analyte sensor dataUS7959582Mar 21, 2007Jun 14, 2011Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS7959715Jun 14, 2011Medtronic Minimed, Inc.Systems and methods allowing for reservoir air bubble managementUS7963954Jun 21, 2011Medtronic Minimed, Inc.Automated filling systems and methodsUS7970448Jun 28, 2011Dexcom, Inc.Device and method for determining analyte levelsUS7974672Jul 5, 2011Dexcom, Inc.Device and method for determining analyte levelsUS7976476Jul 12, 2011Pelikan Technologies, Inc.Device and method for variable speed lancetUS7976492Jul 12, 2011Dexcom, Inc.Integrated delivery device for continuous glucose sensorUS7976778Jul 12, 2011Abbott Diabetes Care Inc.Blood glucose tracking apparatusUS7979104Jul 12, 2011Dexcom, Inc.System and methods for processing analyte sensor dataUS7979227 *Dec 13, 2006Jul 12, 2011Endress + Hauser Conducta Gesellschaft f�r Mess- und Regeltechnik mbH + Co. KGCalibration in a laboratory reference methodUS7981055Dec 22, 2005Jul 19, 2011Pelikan Technologies, Inc.Tissue penetration deviceUS7981056Jun 18, 2007Jul 19, 2011Pelikan Technologies, Inc.Methods and apparatus for lancet actuationUS7986986Mar 23, 2010Jul 26, 2011Dexcom, Inc.System and methods for processing analyte sensor dataUS7988644Aug 2, 2011Pelikan Technologies, Inc.Method and apparatus for a multi-use body fluid sampling device with sterility barrier releaseUS7988645Aug 2, 2011Pelikan Technologies, Inc.Self optimizing lancing device with adaptation means to temporal variations in cutaneous propertiesUS7996054Aug 9, 2011Abbott Diabetes Care Inc.Electrochemical analyte sensorUS7996158May 14, 2008Aug 9, 2011Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS7998071Oct 14, 2009Aug 16, 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8000901Aug 16, 2011Dexcom, Inc.Transcutaneous analyte sensorUS8005524Aug 23, 2011Dexcom, Inc.Signal processing for continuous analyte sensorUS8005525Aug 23, 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8007446Aug 30, 2011Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS8010174Aug 22, 2003Aug 30, 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8016774Dec 22, 2005Sep 13, 2011Pelikan Technologies, Inc.Tissue penetration deviceUS8025658Sep 27, 2011Medtronic Minimed, Inc.Adhesive patch systems and methodsUS8026104Oct 21, 2007Sep 27, 2011Bayer Healthcare LlcTransient decay amperometryUS8029441 *Feb 28, 2006Oct 4, 2011Abbott Diabetes Care Inc.Analyte sensor transmitter unit configuration for a data monitoring and management systemUS8050731Nov 1, 2011Dexcom, Inc.Techniques to improve polyurethane membranes for implantable glucose sensorsUS8052601Nov 8, 2011Dexcom, Inc.System and methods for processing analyte sensor dataUS8053018Jan 15, 2010Nov 8, 2011Dexcom, Inc.Techniques to improve polyurethane membranes for implantable glucose sensorsUS8060173Nov 15, 2011Dexcom, Inc.System and methods for processing analyte sensor dataUS8060174Apr 14, 2006Nov 15, 2011Dexcom, Inc.Analyte sensing biointerfaceUS8062231Nov 22, 2011Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS8064977Jul 29, 2009Nov 22, 2011Dexcom, Inc.Silicone based membranes for use in implantable glucose sensorsUS8066639Jun 4, 2004Nov 29, 2011Abbott Diabetes Care Inc.Glucose measuring device for use in personal area networkUS8073519Oct 14, 2009Dec 6, 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8073520Dec 6, 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8079960Oct 10, 2006Dec 20, 2011Pelikan Technologies, Inc.Methods and apparatus for lancet actuationUS8083716Dec 27, 2011Medtronic Minimed, Inc.Systems and methods allowing for reservoir air bubble managementUS8086292Oct 27, 2009Dec 27, 2011Abbott Diabetes Care Inc.Analyte monitoring and management system and methods thereforUS8103456Jan 24, 2012Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS8103471May 14, 2008Jan 24, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8112240Apr 29, 2005Feb 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing leak detection in data monitoring and management systemsUS8116840Oct 30, 2007Feb 14, 2012Abbott Diabetes Care Inc.Method of calibrating of an analyte-measurement device, and associated methods, devices and systemsUS8118877Jan 17, 2007Feb 21, 2012Dexcom, Inc.Porous membranes for use with implantable devicesUS8121857Feb 14, 2008Feb 21, 2012Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detectionUS8123686Mar 1, 2007Feb 28, 2012Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systemsUS8123700Jun 26, 2007Feb 28, 2012Pelikan Technologies, Inc.Method and apparatus for lancet launching device integrated onto a blood-sampling cartridgeUS8128562Oct 14, 2009Mar 6, 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8133178Feb 22, 2006Mar 13, 2012Dexcom, Inc.Analyte sensorUS8135548Oct 26, 2007Mar 13, 2012Abbott Diabetes Care Inc.Method, system and computer program product for real-time detection of sensitivity decline in analyte sensorsUS8137314Oct 27, 2006Mar 20, 2012Medtronic Minimed, Inc.Infusion medium delivery device and method with compressible or curved reservoir or conduitUS8140142Apr 14, 2008Mar 20, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication systemUS8140312Jan 31, 2008Mar 20, 2012Abbott Diabetes Care Inc.Method and system for determining analyte levelsUS8147674Nov 14, 2008Apr 3, 2012Bayer Healthcare LlcRapid-read gated amperometryUS8149103May 23, 2011Apr 3, 2012Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage amplification in a medical deviceUS8149117Aug 29, 2009Apr 3, 2012Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8150488Oct 14, 2009Apr 3, 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8155723Jan 28, 2010Apr 10, 2012Dexcom, Inc.Device and method for determining analyte levelsUS8157748Jan 10, 2008Apr 17, 2012Pelikan Technologies, Inc.Methods and apparatus for lancet actuationUS8160669Apr 17, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8160670Jul 3, 2008Apr 17, 2012Abbott Diabetes Care Inc.Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agentUS8160671Apr 17, 2012Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS8160834Jun 2, 2011Apr 17, 2012Medtronic Minimed, Inc.Methods and systems for observing sensor parametersUS8160900Apr 17, 2012Abbott Diabetes Care Inc.Analyte monitoring and management device and method to analyze the frequency of user interaction with the deviceUS8162829Mar 30, 2009Apr 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8162853Apr 24, 2012Pelikan Technologies, Inc.Tissue penetration deviceUS8167801May 1, 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8170803 *May 1, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8172804Jul 11, 2008May 8, 2012Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS8172929May 8, 2012Medtronic Minimed, Inc.Systems and methods allowing for reservoir air bubble managementUS8175673 *Nov 9, 2009May 8, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8177716 *Dec 21, 2009May 15, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8185181May 22, 2012Abbott Diabetes Care Inc.Method and apparatus for detecting false hypoglycemic conditionsUS8187183Oct 11, 2010May 29, 2012Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of useUS8187228May 29, 2012Medtronic Minimed, Inc.Infusion pumps and methods and delivery devices and methods with sameUS8195265Feb 9, 2011Jun 5, 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8197421Jul 16, 2007Jun 12, 2012Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS8197423Dec 14, 2010Jun 12, 2012Pelikan Technologies, Inc.Method and apparatus for penetrating tissueUS8202231Apr 23, 2007Jun 19, 2012Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8202250Jun 19, 2012Medtronic Minimed, Inc.Infusion pumps and methods and delivery devices and methods with sameUS8206297Jun 26, 2012Dexcom, Inc.System and methods for processing analyte sensor dataUS8206317Dec 22, 2005Jun 26, 2012Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8206319Jun 26, 2012Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8211016Jul 3, 2012Abbott Diabetes Care Inc.Method and system for providing analyte monitoringUS8211037Jul 3, 2012Pelikan Technologies, Inc.Tissue penetration deviceUS8216137Jul 20, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method and system for providing analyte monitoringUS8216138Jul 10, 2012Abbott Diabetes Care Inc.Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentrationUS8216139Sep 23, 2009Jul 10, 2012Dexcom, Inc.Signal processing for continuous analyte sensorUS8216154Jul 10, 2012Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8219173Sep 30, 2008Jul 10, 2012Abbott Diabetes Care Inc.Optimizing analyte sensor calibrationUS8219174Jun 29, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS8219175Jun 29, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS8221334Jul 17, 2012Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8224410Dec 10, 2004Jul 17, 2012Hadvary PaulDermally affixed sensor deviceUS8224413Oct 10, 2008Jul 17, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8224415Jan 29, 2009Jul 17, 2012Abbott Diabetes Care Inc.Method and device for providing offset model based calibration for analyte sensorUS8226555Mar 18, 2009Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8226557Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8226558Sep 27, 2010Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8226615Nov 24, 2008Jul 24, 2012Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS8226891Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring devices and methods thereforUS8229534Jul 24, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8229535Jul 24, 2012Dexcom, Inc.Systems and methods for blood glucose monitoring and alert deliveryUS8229536Jul 24, 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8231531Jul 31, 2012Dexcom, Inc.Analyte sensorUS8231532Apr 30, 2007Jul 31, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8233958Oct 12, 2009Jul 31, 2012Dexcom, Inc.Signal processing for continuous analyte sensorUS8233959Jul 31, 2012Dexcom, Inc.Systems and methods for processing analyte sensor dataUS8235896 *Dec 21, 2009Aug 7, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8235915Dec 18, 2008Aug 7, 2012Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8236242Feb 12, 2010Aug 7, 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methodsUS8239166Aug 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8249683 *Jun 29, 2010Aug 21, 2012Medtronic Minimed, Inc.Real-time self-calibrating sensor system and methodUS8249684Aug 21, 2012Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS8251906Apr 15, 2009Aug 28, 2012Dexcom, Inc.Signal processing for continuous analyte sensorUS8251921Jun 10, 2010Aug 28, 2012Sanofi-Aventis Deutschland GmbhMethod and apparatus for body fluid sampling and analyte sensingUS8252229Apr 10, 2009Aug 28, 2012Abbott Diabetes Care Inc.Method and system for sterilizing an analyte sensorUS8255030Apr 25, 2006Aug 28, 2012Dexcom, Inc.Oxygen enhancing membrane systems for implantable devicesUS8255031Mar 17, 2009Aug 28, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8255032Jan 15, 2010Aug 28, 2012Dexcom, Inc.Oxygen enhancing membrane systems for implantable devicesUS8255033Apr 25, 2006Aug 28, 2012Dexcom, Inc.Oxygen enhancing membrane systems for implantable devicesUS8257259Sep 4, 2012Dexcom, Inc.Signal processing for continuous analyte sensorUS8260392Sep 4, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8260393Sep 4, 2012Dexcom, Inc.Systems and methods for replacing signal data artifacts in a glucose sensor data streamUS8260558May 14, 2008Sep 4, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8262614Jun 1, 2004Sep 11, 2012Pelikan Technologies, Inc.Method and apparatus for fluid injectionUS8262899Jul 10, 2009Sep 11, 2012Bayer Healthcare LlcSystems and methods including amperometric and voltammetric duty cyclesUS8264215 *Sep 11, 2012The Boeing CompanyOnboard electrical current sensing systemUS8265725Sep 11, 2012Dexcom, Inc.Signal processing for continuous analyte sensorUS8265726Sep 11, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8267870May 30, 2003Sep 18, 2012Sanofi-Aventis Deutschland GmbhMethod and apparatus for body fluid sampling with hybrid actuationUS8268243Dec 28, 2009Sep 18, 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methodsUS8273022Sep 25, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8275437Mar 23, 2007Sep 25, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8275438Sep 25, 2012Dexcom, Inc.Analyte sensorUS8275439Nov 9, 2009Sep 25, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8277415Nov 22, 2006Oct 2, 2012Medtronic Minimed, Inc.Infusion medium delivery device and method with drive device for driving plunger in reservoirUS8277713May 3, 2004Oct 2, 2012Dexcom, Inc.Implantable analyte sensorUS8280475Feb 23, 2009Oct 2, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8280476Oct 2, 2012Arkal Medical, Inc.Devices, systems, methods and tools for continuous glucose monitoringUS8282549Oct 9, 2012Dexcom, Inc.Signal processing for continuous analyte sensorUS8282550Jul 29, 2008Oct 9, 2012Dexcom, Inc.Integrated receiver for continuous analyte sensorUS8282576Sep 29, 2004Oct 9, 2012Sanofi-Aventis Deutschland GmbhMethod and apparatus for an improved sample capture deviceUS8282577Oct 9, 2012Sanofi-Aventis Deutschland GmbhMethod and apparatus for lancet launching device integrated onto a blood-sampling cartridgeUS8285354Mar 23, 2010Oct 9, 2012Dexcom, Inc.System and methods for processing analyte sensor dataUS8287453Nov 7, 2008Oct 16, 2012Dexcom, Inc.Analyte sensorUS8287454Oct 16, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8287495Oct 10, 2011Oct 16, 2012Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedbackUS8290559Oct 24, 2008Oct 16, 2012Dexcom, Inc.Systems and methods for processing sensor dataUS8290560Oct 16, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8290561Oct 16, 2012Dexcom, Inc.Signal processing for continuous analyte sensorUS8290562Oct 16, 2012Dexcom, Inc.System and methods for processing analyte sensor dataUS8292810Jan 27, 2011Oct 23, 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8296918Aug 23, 2010Oct 30, 2012Sanofi-Aventis Deutschland GmbhMethod of manufacturing a fluid sampling device with improved analyte detecting member configurationUS8298142Oct 30, 2012Dexcom, Inc.Analyte sensorUS8298184Oct 30, 2012Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedbackUS8303574Nov 6, 2012Deka Products Limited PartnershipAdhesive and peripheral systems and methods for medical devicesUS8306598Nov 9, 2009Nov 6, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8311749Nov 13, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8313434Nov 20, 2012Dexcom, Inc.Analyte sensor inserter systemUS8321149Nov 27, 2012Dexcom, Inc.Transcutaneous analyte sensorUS8323250Dec 4, 2012Medtronic Minimed, Inc.Adhesive patch systems and methodsUS8332008Mar 23, 2010Dec 11, 2012Dexcom, Inc.System and methods for processing analyte sensor dataUS8333710Dec 18, 2012Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8333714Sep 10, 2006Dec 18, 2012Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unitUS8337419Oct 4, 2005Dec 25, 2012Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8337420Mar 24, 2006Dec 25, 2012Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8337421Dec 16, 2008Dec 25, 2012Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8343075Dec 23, 2005Jan 1, 2013Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8346335Jan 1, 2013Abbott Diabetes Care Inc.Analyte sensor calibration managementUS8346336Mar 18, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8346337Jun 30, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8346338Jan 1, 2013Dexcom, Inc.System and methods for replacing signal artifacts in a glucose sensor data streamUS8353829Dec 21, 2009Jan 15, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8357091Jan 22, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8360991Dec 23, 2005Jan 29, 2013Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8360992Nov 25, 2008Jan 29, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8362904Jan 29, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8364230Jan 29, 2013Dexcom, Inc.Analyte sensorUS8364231Jan 29, 2013Dexcom, Inc.Analyte sensorUS8366614Mar 30, 2009Feb 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8366637Feb 5, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8368556Feb 5, 2013Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management systemUS8369919Oct 24, 2008Feb 5, 2013Dexcom, Inc.Systems and methods for processing sensor dataUS8372005Dec 21, 2009Feb 12, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8372016Feb 12, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for body fluid sampling and analyte sensingUS8374667Oct 16, 2008Feb 12, 2013Dexcom, Inc.Signal processing for continuous analyte sensorUS8374668Oct 23, 2008Feb 12, 2013Abbott Diabetes Care Inc.Analyte sensor with lag compensationUS8376945Nov 23, 2009Feb 19, 2013Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring systemUS8377031Aug 31, 2008Feb 19, 2013Abbott Diabetes Care Inc.Closed loop control system with safety parameters and methodsUS8380273Feb 19, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8382682Feb 26, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8382683Feb 26, 2013Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8386004Feb 26, 2013Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS8388551May 27, 2008Mar 5, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for multi-use body fluid sampling device with sterility barrier releaseUS8391945Mar 17, 2009Mar 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8394021Mar 12, 2013Dexcom, Inc.System and methods for processing analyte sensor dataUS8396528 *Mar 12, 2013Dexcom, Inc.Analyte sensorUS8403864May 1, 2006Mar 26, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8404100Mar 26, 2013Bayer Healthcare LlcGated voltammetryUS8408421Apr 2, 2013Tandem Diabetes Care, Inc.Flow regulating stopcocks and related methodsUS8409093Apr 2, 2013Abbott Diabetes Care Inc.Assessing measures of glycemic variabilityUS8409131Mar 7, 2007Apr 2, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8412301Apr 2, 2013Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8414503Apr 9, 2013Sanofi-Aventis Deutschland GmbhMethods and apparatus for lancet actuationUS8417312Oct 24, 2008Apr 9, 2013Dexcom, Inc.Systems and methods for processing sensor dataUS8417545Apr 9, 2013Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detectionUS8423113Apr 16, 2013Dexcom, Inc.Systems and methods for processing sensor dataUS8423114Oct 1, 2007Apr 16, 2013Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS8425416Apr 23, 2013Dexcom, Inc.Analyte sensorUS8425417Apr 23, 2013Dexcom, Inc.Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion deviceUS8425757Apr 23, 2013Bayer Healthcare LlcGated amperometryUS8427298Apr 23, 2013Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage amplification in a medical deviceUS8428678Apr 23, 2013Dexcom, Inc.Calibration techniques for a continuous analyte sensorUS8428679Mar 26, 2010Apr 23, 2013Dexcom, Inc.System and methods for processing analyte sensor dataUS8430828Jan 26, 2007Apr 30, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for a multi-use body fluid sampling device with sterility barrier releaseUS8434528Apr 29, 2008May 7, 2013Medtronic Minimed, Inc.Systems and methods for reservoir fillingUS8435179Jan 27, 2011May 7, 2013Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8435190Jan 19, 2007May 7, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8439872Apr 26, 2010May 14, 2013Sanofi-Aventis Deutschland GmbhApparatus and method for penetration with shaft having a sensor for sensing penetration depthUS8442610Aug 21, 2008May 14, 2013Dexcom, Inc.System and methods for processing analyte sensor dataUS8444560May 14, 2008May 21, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8444607Oct 8, 2008May 21, 2013Medtronic Minimed, Inc.Infusion medium delivery device and method with drive device for driving plunger in reservoirUS8447376May 21, 2013Dexcom, Inc.Analyte sensorUS8448824Feb 26, 2009May 28, 2013Tandem Diabetes Care, Inc.Slideable flow metering devices and related methodsUS8449464May 28, 2013Dexcom, Inc.Analyte sensorUS8452368May 28, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8456301May 8, 2008Jun 4, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8457708Jun 4, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8461985May 8, 2008Jun 11, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8463350Jun 11, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8463351Aug 6, 2010Jun 11, 2013Abbott Diabetes Care Inc.Electrochemical analyte sensorUS8465425Jun 18, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8469886Sep 23, 2009Jun 25, 2013Dexcom, Inc.Signal processing for continuous analyte sensorUS8470604Aug 16, 2011Jun 25, 2013Bayer Healthcare LlcTransient decay amperometryUS8473021Jul 31, 2009Jun 25, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8473022Jan 30, 2009Jun 25, 2013Abbott Diabetes Care Inc.Analyte sensor with time lag compensationUS8473220Jan 23, 2012Jun 25, 2013Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS8474397May 6, 2010Jul 2, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8475373Jul 17, 2008Jul 2, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8475432Sep 3, 2010Jul 2, 2013Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS8478377Nov 7, 2008Jul 2, 2013Dexcom, Inc.Analyte sensorUS8478557Jul 30, 2010Jul 2, 2013Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracyUS8480580Apr 19, 2007Jul 9, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8483791Apr 11, 2008Jul 9, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8483793Oct 29, 2010Jul 9, 2013Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS8483967Apr 28, 2010Jul 9, 2013Abbott Diabetes Care Inc.Method and system for providing real time analyte sensor calibration with retrospective backfillUS8484005Mar 19, 2012Jul 9, 2013Abbott Diabetes Care Inc.Method and system for determining analyte levelsUS8491474Jan 27, 2011Jul 23, 2013Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8491500Apr 16, 2007Jul 23, 2013Sanofi-Aventis Deutschland GmbhMethods and apparatus for lancet actuationUS8496601Apr 16, 2007Jul 30, 2013Sanofi-Aventis Deutschland GmbhMethods and apparatus for lancet actuationUS8497777Apr 15, 2010Jul 30, 2013Abbott Diabetes Care Inc.Analyte monitoring system having an alertUS8506162Mar 19, 2009Aug 13, 2013Parker-Hannifin CorporationDisposable, pre-calibrated, pre-validated sensors for use in bio-processing applicationsUS8506482Feb 7, 2011Aug 13, 2013Abbott Diabetes Care Inc.Method and system for providing continuous calibration of implantable analyte sensorsUS8509107Nov 1, 2010Aug 13, 2013Abbott Diabetes Care Inc.Close proximity communication device and methodsUS8509871Oct 28, 2008Aug 13, 2013Dexcom, Inc.Sensor head for use with implantable devicesUS8512239Apr 20, 2009Aug 20, 2013Abbott Diabetes Care Inc.Glucose measuring device for use in personal area networkUS8512243Sep 30, 2005Aug 20, 2013Abbott Diabetes Care Inc.Integrated introducer and transmitter assembly and methods of useUS8512288Sep 1, 2006Aug 20, 2013Medtronic Minimed, Inc.Infusion medium delivery device and method with drive device for driving plunger in reservoirUS8514086Aug 30, 2010Aug 20, 2013Abbott Diabetes Care Inc.Displays for a medical deviceUS8515516Mar 10, 2005Aug 20, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8515517Sep 30, 2009Aug 20, 2013Abbott Diabetes Care Inc.Method and system for dynamically updating calibration parameters for an analyte sensorUS8515518 *Dec 28, 2005Aug 20, 2013Abbott Diabetes Care Inc.Analyte monitoringUS8515519Feb 26, 2009Aug 20, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8527025Nov 22, 1999Sep 3, 2013Dexcom, Inc.Device and method for determining analyte levelsUS8527026Mar 2, 2012Sep 3, 2013Dexcom, Inc.Device and method for determining analyte levelsUS8529553Jul 2, 2009Sep 10, 2013Medtronic Minimed, Inc.Infusion medium delivery device and method with drive device for driving plunger in reservoirUS8532730Oct 4, 2006Sep 10, 2013Dexcom, Inc.Analyte sensorUS8532935Jul 16, 2012Sep 10, 2013Abbott Diabetes Care Inc.Method and device for providing offset model based calibration for analyte sensorUS8543183Dec 23, 2011Sep 24, 2013Abbott Diabetes Care Inc.Analyte monitoring and management system and methods thereforUS8543184Oct 20, 2011Sep 24, 2013Dexcom, Inc.Silicone based membranes for use in implantable glucose sensorsUS8545403Dec 28, 2006Oct 1, 2013Abbott Diabetes Care Inc.Medical device insertionUS8548551May 14, 2010Oct 1, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8548553Jun 22, 2012Oct 1, 2013Dexcom, Inc.System and methods for processing analyte sensor dataUS8556829Jan 27, 2009Oct 15, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8560037Mar 26, 2010Oct 15, 2013Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibrationUS8560038May 14, 2008Oct 15, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8560039Sep 17, 2009Oct 15, 2013Dexcom, Inc.Particle-containing membrane and particulate electrode for analyte sensorsUS8562528Nov 7, 2008Oct 22, 2013Dexcom, Inc.Analyte sensorUS8562545Dec 16, 2008Oct 22, 2013Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8562558Jun 5, 2008Oct 22, 2013Dexcom, Inc.Integrated medicament delivery device for use with continuous analyte sensorUS8565848May 7, 2009Oct 22, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8565849May 14, 2010Oct 22, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8571624Dec 29, 2004Oct 29, 2013Abbott Diabetes Care Inc.Method and apparatus for mounting a data transmission device in a communication systemUS8571625May 14, 2010Oct 29, 2013Dexcom, Inc.Transcutaneous analyte sensorUS8571808Jan 23, 2012Oct 29, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8574168Mar 26, 2007Nov 5, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for a multi-use body fluid sampling device with analyte sensingUS8574895Dec 30, 2003Nov 5, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus using optical techniques to measure analyte levelsUS8579816Jan 7, 2010Nov 12, 2013Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibrationUS8579831Oct 6, 2006Nov 12, 2013Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8583204Mar 5, 2010Nov 12, 2013Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS8583205Apr 16, 2010Nov 12, 2013Abbott Diabetes Care Inc.Analyte sensor calibration managementUS8585591Jul 10, 2010Nov 19, 2013Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systemsUS8588881Mar 2, 2007Nov 19, 2013Abbott Diabetes Care Inc.Subcutaneous glucose electrodeUS8588882Dec 16, 2009Nov 19, 2013Dexcom, Inc.System and methods for processing analyte sensor dataUS8591410Jun 1, 2009Nov 26, 2013Abbott Diabetes Care Inc.Method and apparatus for providing glycemic controlUS8591455Feb 20, 2009Nov 26, 2013Dexcom, Inc.Systems and methods for customizing delivery of sensor dataUS8593109Nov 3, 2009Nov 26, 2013Abbott Diabetes Care Inc.Method and system for powering an electronic deviceUS8593287Jul 20, 2012Nov 26, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8597188Jun 20, 2008Dec 3, 2013Abbott Diabetes Care Inc.Health management devices and methodsUS8597189Mar 3, 2009Dec 3, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8597243Apr 8, 2008Dec 3, 2013Medtronic Minimed, Inc.Systems and methods allowing for reservoir air bubble managementUS8597270Jun 17, 2011Dec 3, 2013Medtronic Minimed, Inc.Automated filling systems and methodsUS8597575Jul 23, 2012Dec 3, 2013Abbott Diabetes Care Inc.Analyte monitoring devices and methods thereforUS8600681May 14, 2008Dec 3, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8602991Jun 7, 2010Dec 10, 2013Abbott Diabetes Care Inc.Analyte sensor introducer and methods of useUS8611978Jan 7, 2010Dec 17, 2013Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibrationUS8612159Feb 16, 2004Dec 17, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8612163Aug 30, 2012Dec 17, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8613703May 29, 2008Dec 24, 2013Abbott Diabetes Care Inc.Insertion devices and methodsUS8613725Apr 8, 2011Dec 24, 2013Medtronic Minimed, Inc.Reservoir systems and methodsUS8613892Jun 30, 2009Dec 24, 2013Abbott Diabetes Care Inc.Analyte meter with a moveable head and methods of using the sameUS8615282Feb 22, 2006Dec 24, 2013Dexcom, Inc.Analyte sensorUS8617069Jun 20, 2008Dec 31, 2013Abbott Diabetes Care Inc.Health monitorUS8617071Jun 21, 2007Dec 31, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8622903May 25, 2012Jan 7, 2014Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of useUS8622905Dec 11, 2009Jan 7, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8622906Dec 21, 2009Jan 7, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8622930Jul 18, 2011Jan 7, 2014Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8622988Aug 31, 2008Jan 7, 2014Abbott Diabetes Care Inc.Variable rate closed loop control and methodsUS8626257Nov 7, 2008Jan 7, 2014Dexcom, Inc.Analyte sensorUS8635046Jun 22, 2011Jan 21, 2014Abbott Diabetes Care Inc.Method and system for evaluating analyte sensor response characteristicsUS8636673Dec 1, 2008Jan 28, 2014Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8641619Dec 21, 2009Feb 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8641643Apr 27, 2006Feb 4, 2014Sanofi-Aventis Deutschland GmbhSampling module device and methodUS8641644Apr 23, 2008Feb 4, 2014Sanofi-Aventis Deutschland GmbhBlood testing apparatus having a rotatable cartridge with multiple lancing elements and testing meansUS8647269Apr 20, 2009Feb 11, 2014Abbott Diabetes Care Inc.Glucose measuring device for use in personal area networkUS8647489Feb 28, 2013Feb 11, 2014Bayer Healthcare LlcGated voltammetry devicesUS8649841Apr 3, 2007Feb 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8650937Sep 18, 2009Feb 18, 2014Tandem Diabetes Care, Inc.Solute concentration measurement device and related methodsUS8652043Jul 20, 2012Feb 18, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8652831Mar 26, 2008Feb 18, 2014Sanofi-Aventis Deutschland GmbhMethod and apparatus for analyte measurement test timeUS8657745Oct 16, 2008Feb 25, 2014Dexcom, Inc.Signal processing for continuous analyte sensorUS8657747Apr 5, 2011Feb 25, 2014Dexcom, Inc.Systems and methods for processing analyte sensor dataUS8660627Mar 17, 2009Feb 25, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8663109Mar 29, 2010Mar 4, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8665091Jun 30, 2009Mar 4, 2014Abbott Diabetes Care Inc.Method and device for determining elapsed sensor lifeUS8666469Nov 16, 2007Mar 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8668645Jan 3, 2003Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8668656Dec 31, 2004Mar 11, 2014Sanofi-Aventis Deutschland GmbhMethod and apparatus for improving fluidic flow and sample captureUS8670815Apr 30, 2007Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8672844 *Feb 27, 2004Mar 18, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8672845Mar 25, 2010Mar 18, 2014Dexcom, Inc.Systems and methods for processing analyte sensor dataUS8676287Dec 11, 2009Mar 18, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8676288Jun 22, 2011Mar 18, 2014Dexcom, Inc.Device and method for determining analyte levelsUS8676513Jun 21, 2013Mar 18, 2014Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS8676601Apr 8, 2013Mar 18, 2014Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detectionUS8679033Jun 16, 2011Mar 25, 2014Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8682408Mar 5, 2010Mar 25, 2014Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS8682615Aug 4, 2012Mar 25, 2014Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8684930Jun 29, 2009Apr 1, 2014Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS8688188Jun 30, 2009Apr 1, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8690775Apr 11, 2008Apr 8, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8690796Sep 29, 2006Apr 8, 2014Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS8698615Apr 22, 2013Apr 15, 2014Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS8700117Dec 8, 2009Apr 15, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8702624Jan 29, 2010Apr 22, 2014Sanofi-Aventis Deutschland GmbhAnalyte measurement device with a single shot actuatorUS8706180Jun 10, 2013Apr 22, 2014Abbott Diabetes Care Inc.Electrochemical analyte sensorUS8710993Nov 21, 2012Apr 29, 2014Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereofUS8718739Dec 28, 2012May 6, 2014Abbott Diabetes Care Inc.Analyte sensor calibration managementUS8718958Mar 12, 2012May 6, 2014Abbott Diabetes Care Inc.Method, system and computer program product for real-time detection of sensitivity decline in analyte sensorsUS8718965Jun 24, 2013May 6, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracyUS8721544Mar 20, 2008May 13, 2014Roche Diagnostics Operations, Inc.System for in-vivo measurement of an analyte concentrationUS8721545Mar 22, 2010May 13, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8721585Mar 30, 2012May 13, 2014Dex Com, Inc.Integrated delivery device for continuous glucose sensorUS8721671Jul 6, 2005May 13, 2014Sanofi-Aventis Deutschland GmbhElectric lancet actuatorUS8730058Jul 29, 2013May 20, 2014Abbott Diabetes Care Inc.Analyte monitoring system having an alertUS8731630Mar 22, 2010May 20, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8732188Feb 15, 2008May 20, 2014Abbott Diabetes Care Inc.Method and system for providing contextual based medication dosage determinationUS8734344May 29, 2011May 27, 2014Abbott Diabetes Care Inc.On-body medical device securementUS8734346Apr 30, 2007May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8734348Mar 17, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8734422Aug 31, 2008May 27, 2014Abbott Diabetes Care Inc.Closed loop control with improved alarm functionsUS8737259Aug 5, 2013May 27, 2014Abbott Diabetes Care Inc.Close proximity communication device and methodsUS8738109Mar 3, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8741590Apr 3, 2007Jun 3, 2014Abbott Diabetes Care Inc.Subcutaneous glucose electrodeUS8744545Mar 3, 2009Jun 3, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8744546Apr 28, 2006Jun 3, 2014Dexcom, Inc.Cellulosic-based resistance domain for an analyte sensorUS8744547Jul 9, 2012Jun 3, 2014Abbott Diabetes Care Inc.Optimizing analyte sensor calibrationUS8744776Jun 6, 2011Jun 3, 2014Bayer Healthcare LlcMethod for determining analyte concentration based on complex index functionsUS8747315Sep 23, 2009Jun 10, 2014Dexcom. Inc.Signal processing for continuous analyte sensorUS8750955Nov 2, 2009Jun 10, 2014Dexcom, Inc.Analyte sensorUS8758323Jul 29, 2010Jun 24, 2014Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedbackUS8761856Apr 27, 2012Jun 24, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8764657Mar 30, 2012Jul 1, 2014Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS8765059Oct 27, 2010Jul 1, 2014Abbott Diabetes Care Inc.Blood glucose tracking apparatusUS8771183Feb 16, 2005Jul 8, 2014Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management systemUS8771187May 31, 2011Jul 8, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8774886Oct 4, 2006Jul 8, 2014Dexcom, Inc.Analyte sensorUS8774887Mar 24, 2007Jul 8, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8774888Jan 20, 2010Jul 8, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8777852Aug 22, 2007Jul 15, 2014Medtronic Minimed, Inc.System and method for sensor recalibrationUS8777853Apr 4, 2012Jul 15, 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8784335Jul 25, 2008Jul 22, 2014Sanofi-Aventis Deutschland GmbhBody fluid sampling device with a capacitive sensorUS8788006Dec 11, 2009Jul 22, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8788007Mar 8, 2012Jul 22, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8788008May 31, 2011Jul 22, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8790260Oct 14, 2009Jul 29, 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8792953Mar 19, 2010Jul 29, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8792954Mar 19, 2010Jul 29, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8792955Jun 9, 2011Jul 29, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8792956Apr 2, 2012Jul 29, 2014Abbott Diabetes Care Inc.Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agentUS8795177Jan 14, 2009Aug 5, 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8795230Nov 22, 2011Aug 5, 2014Becton, Dickinson And CompanyAdjustable height needle infusion deviceUS8795252Oct 16, 2009Aug 5, 2014Abbott Diabetes Care Inc.Robust closed loop control and methodsUS8801610Jul 24, 2009Aug 12, 2014Dexcom, Inc.Signal processing for continuous analyte sensorUS8801611Mar 22, 2010Aug 12, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8801612Apr 27, 2012Aug 12, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8802006Aug 27, 2012Aug 12, 2014Abbott Diabetes Care Inc.Method and system for sterilizing an analyte sensorUS8808182Apr 27, 2012Aug 19, 2014Dexcom, Inc.System and methods for processing analyte sensor dataUS8808201 *Jan 15, 2008Aug 19, 2014Sanofi-Aventis Deutschland GmbhMethods and apparatus for penetrating tissueUS8808228Jun 5, 2008Aug 19, 2014Dexcom, Inc.Integrated medicament delivery device for use with continuous analyte sensorUS8812072Apr 17, 2008Aug 19, 2014Dexcom, Inc.Transcutaneous medical device with variable stiffnessUS8812073Jun 1, 2010Aug 19, 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8814831Nov 22, 2011Aug 26, 2014Becton, Dickinson And CompanyBallistic microneedle infusion deviceUS8816862Aug 19, 2013Aug 26, 2014Abbott Diabetes Care Inc.Displays for a medical deviceUS8821400Feb 9, 2011Sep 2, 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8825127May 14, 2010Sep 2, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8828203May 20, 2005Sep 9, 2014Sanofi-Aventis Deutschland GmbhPrintable hydrogels for biosensorsUS8834366Jul 31, 2007Sep 16, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor calibrationUS8840552Dec 8, 2009Sep 23, 2014Dexcom, Inc.Membrane for use with implantable devicesUS8840553Feb 26, 2009Sep 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8840586Oct 27, 2006Sep 23, 2014Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS8840587Jan 13, 2009Sep 23, 2014Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS8843187Jun 1, 2010Sep 23, 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS8845530 *Dec 28, 2007Sep 30, 2014Isense CorporationResposable biosensor assembly and method of sensingUS8845536Apr 11, 2007Sep 30, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8845549Dec 2, 2008Sep 30, 2014Sanofi-Aventis Deutschland GmbhMethod for penetrating tissueUS8845550Dec 3, 2012Sep 30, 2014Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8852101Sep 30, 2009Oct 7, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertionUS8858434Mar 10, 2005Oct 14, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8862198Dec 17, 2012Oct 14, 2014Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unitUS8865249Sep 28, 2012Oct 21, 2014Dexcom, Inc.Techniques to improve polyurethane membranes for implantable glucose sensorsUS8871070Jul 19, 2012Oct 28, 2014Bayer Healthcare LlcSystems, methods, and devices including amperometric and voltammetric duty cyclesUS8876755Jul 14, 2009Nov 4, 2014Abbott Diabetes Care Inc.Closed loop control system interface and methodsUS8877035Mar 28, 2013Nov 4, 2014Bayer Healthcare LlcGated amperometry methodsUS8880137Apr 18, 2003Nov 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8880138Sep 30, 2005Nov 4, 2014Abbott Diabetes Care Inc.Device for channeling fluid and methods of useUS8886272Feb 22, 2006Nov 11, 2014Dexcom, Inc.Analyte sensorUS8886273Nov 7, 2008Nov 11, 2014Dexcom, Inc.Analyte sensorUS8905945Mar 29, 2012Dec 9, 2014Dominique M. FreemanMethod and apparatus for penetrating tissueUS8911367Mar 26, 2007Dec 16, 2014Dexcom, Inc.Analyte sensorUS8911369Dec 15, 2008Dec 16, 2014Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS8915849Feb 3, 2009Dec 23, 2014Dexcom, Inc.Transcutaneous analyte sensorUS8915850Mar 28, 2014Dec 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8920319Dec 28, 2012Dec 30, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8923947Jul 23, 2013Dec 30, 2014Dexcom, Inc.Device and method for determining analyte levelsUS8924159Jun 1, 2009Dec 30, 2014Abbott Diabetes Care Inc.Method and apparatus for providing glycemic controlUS8926561Jul 29, 2010Jan 6, 2015Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedbackUS8926585Mar 30, 2012Jan 6, 2015Dexcom, Inc.Integrated delivery device for continuous glucose sensorUS8929968Jul 19, 2010Jan 6, 2015Dexcom, Inc.Dual electrode system for a continuous analyte sensorUS8930203Feb 3, 2010Jan 6, 2015Abbott Diabetes Care Inc.Multi-function analyte test device and methods thereforUS8933664Nov 25, 2013Jan 13, 2015Abbott Diabetes Care Inc.Method and system for powering an electronic deviceUS8937540Feb 24, 2014Jan 20, 2015Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS8939928Jul 23, 2009Jan 27, 2015Becton, Dickinson And CompanyMedical device having capacitive coupling communication and energy harvestingUS8945910Jun 19, 2012Feb 3, 2015Sanofi-Aventis Deutschland GmbhMethod and apparatus for an improved sample capture deviceUS8954128Oct 18, 2013Feb 10, 2015Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS8965476Apr 18, 2011Feb 24, 2015Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS8968345 *Feb 11, 2009Mar 3, 2015Covidien LpSurgical introducer with indicatorsUS8974386Nov 1, 2005Mar 10, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8986208Sep 30, 2008Mar 24, 2015Abbott Diabetes Care Inc.Analyte sensor sensitivity attenuation mitigationUS8986209Jul 13, 2012Mar 24, 2015Dexcom, Inc.Transcutaneous analyte sensorUS8986253Aug 7, 2009Mar 24, 2015Tandem Diabetes Care, Inc.Two chamber pumps and related methodsUS8989833Mar 10, 2005Mar 24, 2015Dexcom, Inc.Transcutaneous analyte sensorUS8993331Aug 31, 2010Mar 31, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods for managing power and noiseUS9000929Nov 22, 2013Apr 7, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9005527May 29, 2013Apr 14, 2015Bayer Healthcare LlcTransient decay amperometry biosensorsUS9008743Apr 14, 2008Apr 14, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication systemUS9008745 *Mar 14, 2014Apr 14, 2015Sano Intelligence, Inc.On-body microsensor for biomonitoringUS9011331Dec 29, 2004Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9011332Oct 30, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9014773Mar 7, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9020572Sep 10, 2010Apr 28, 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor dataUS9028409 *Dec 21, 2007May 12, 2015Roche Diagnostics Operations, Inc.Fluid delivery with in vivo electrochemical analyte sensingUS9031630Nov 1, 2010May 12, 2015Abbott Diabetes Care Inc.Analyte sensors and methods of useUS9034160Feb 21, 2012May 19, 2015Bayer Healthcare LlcRapid-read gated amperometry devicesUS9034639Jun 26, 2012May 19, 2015Sanofi-Aventis Deutschland GmbhMethod and apparatus using optical techniques to measure analyte levelsUS9035767May 30, 2013May 19, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9039975Dec 2, 2013May 26, 2015Abbott Diabetes Care Inc.Analyte monitoring devices and methods thereforUS9042953Mar 2, 2007May 26, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9044199Mar 10, 2005Jun 2, 2015Dexcom, Inc.Transcutaneous analyte sensorUS9050041May 21, 2012Jun 9, 2015Abbott Diabetes Care Inc.Method and apparatus for detecting false hypoglycemic conditionsUS9055901Sep 14, 2012Jun 16, 2015Dexcom, Inc.Transcutaneous analyte sensorUS9060719Dec 13, 2013Jun 23, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS9060742Mar 19, 2010Jun 23, 2015Dexcom, Inc.Transcutaneous analyte sensorUS9066694Apr 3, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9066695Apr 12, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9066697Oct 27, 2011Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9066709Mar 17, 2014Jun 30, 2015Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS9069536Oct 30, 2012Jun 30, 2015Abbott Diabetes Care Inc.Electronic devices having integrated reset systems and methods thereofUS9072477Jun 21, 2007Jul 7, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9072842Jul 31, 2013Jul 7, 2015Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS9078607Jun 17, 2013Jul 14, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9078608Jul 13, 2012Jul 14, 2015Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibrationUS9078626Mar 31, 2011Jul 14, 2015Dexcom, Inc.Transcutaneous analyte sensorUS9088452Jan 31, 2013Jul 21, 2015Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management systemUS9089294Jan 16, 2014Jul 28, 2015Sanofi-Aventis Deutschland GmbhAnalyte measurement device with a single shot actuatorUS9089678May 21, 2012Jul 28, 2015Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS9095290Feb 27, 2012Aug 4, 2015Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systemsUS9107623Apr 15, 2009Aug 18, 2015Dexcom, Inc.Signal processing for continuous analyte sensorUS9110013Dec 20, 2013Aug 18, 2015Bayer Healthcare LlcGated voltammetry methodsUS9113828Jul 9, 2012Aug 25, 2015Abbott Diabetes Care Inc.Method and system for providing analyte monitoringUS9125548May 14, 2008Sep 8, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS9125607Dec 29, 2011Sep 8, 2015Medtronic Minimed, Inc.Real-time self-calibrating sensor system and methodUS9125608Jul 16, 2012Sep 8, 2015Medtronic Minimed, Inc.Real-time self-calibrating sensor system and methodUS9135402Oct 24, 2008Sep 15, 2015Dexcom, Inc.Systems and methods for processing sensor dataUS9143569Feb 20, 2009Sep 22, 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor dataUS9144401Dec 12, 2005Sep 29, 2015Sanofi-Aventis Deutschland GmbhLow pain penetrating memberUS9149219Feb 9, 2011Oct 6, 2015Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS9149233Jun 13, 2012Oct 6, 2015Dexcom, Inc.Systems and methods for processing sensor dataUS9149234Jun 13, 2012Oct 6, 2015Dexcom, Inc.Systems and methods for processing sensor dataUS9155496Feb 18, 2011Oct 13, 2015Dexcom, Inc.Low oxygen in vivo analyte sensorUS9164076May 27, 2011Oct 20, 2015Bayer Healthcare LlcSlope-based compensation including secondary output signalsUS9173606Jan 30, 2014Nov 3, 2015Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS9173607Jan 30, 2014Nov 3, 2015Dexcom, Inc.Polymer membranes for continuous analyte sensorsUS9177456Jun 10, 2013Nov 3, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9178752Apr 25, 2014Nov 3, 2015Abbott Diabetes Care Inc.Analyte monitoring system having an alertUS9179869Sep 10, 2014Nov 10, 2015Dexcom, Inc.Techniques to improve polyurethane membranes for implantable glucose sensorsUS9180248Jun 4, 2010Nov 10, 2015Medtronic Minimed, Inc.Infusion device with base portion and durable portionUS9184875Apr 25, 2014Nov 10, 2015Abbott Diabetes Care, Inc.Close proximity communication device and methodsUS9186098Mar 24, 2011Nov 17, 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS9186113Aug 11, 2014Nov 17, 2015Abbott Diabetes Care Inc.Displays for a medical deviceUS9186468Jan 14, 2014Nov 17, 2015Sanofi-Aventis Deutschland GmbhMethod and apparatus for penetrating tissueUS9188525 *Feb 13, 2015Nov 17, 2015Agamatrix, Inc.Method and apparatus for assay of electrochemical propertiesUS9192328Sep 23, 2009Nov 24, 2015Dexcom, Inc.Signal processing for continuous analyte sensorUS9204827Apr 14, 2008Dec 8, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication systemUS9211377Jul 29, 2010Dec 15, 2015Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedbackUS9215992Mar 24, 2011Dec 22, 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS9220449Jul 9, 2013Dec 29, 2015Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibrationUS9226699Nov 9, 2010Jan 5, 2016Sanofi-Aventis Deutschland GmbhBody fluid sampling module with a continuous compression tissue interface surfaceUS9226701Apr 28, 2010Jan 5, 2016Abbott Diabetes Care Inc.Error detection in critical repeating data in a wireless sensor systemUS9226714Jan 8, 2015Jan 5, 2016Abbott Diabetes Care Inc.Displays for a medical deviceUS9228978Oct 14, 2014Jan 5, 2016Bayer Healthcare LlcIdentifying ionizable species with voltammetric duty cyclesUS9233203Aug 23, 2005Jan 12, 2016Medtronic Minimed, Inc.Medical needles for damping motionUS9247900Jun 4, 2013Feb 2, 2016Dexcom, Inc.Analyte sensorUS9247901Aug 2, 2006Feb 2, 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS9248267Jul 18, 2013Feb 2, 2016Sanofi-Aventis Deustchland GmbhTissue penetration deviceUS9259175Oct 23, 2006Feb 16, 2016Abbott Diabetes Care, Inc.Flexible patch for fluid delivery and monitoring body analytesUS9259531Nov 2, 2012Feb 16, 2016Deka Products Limited PartnershipAdhesive and peripheral systems and methods for medical devicesUS9261476Apr 1, 2014Feb 16, 2016Sanofi SaPrintable hydrogel for biosensorsUS9265453Mar 24, 2011Feb 23, 2016Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS9282925Mar 25, 2010Mar 15, 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data streamUS9289179Apr 11, 2014Mar 22, 2016Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereofUS9295786 *May 28, 2008Mar 29, 2016Medtronic Minimed, Inc.Needle protective device for subcutaneous sensorsUS9310230Jun 24, 2013Apr 12, 2016Abbott Diabetes Care Inc.Method and system for providing real time analyte sensor calibration with retrospective backfillUS9314194Jan 11, 2007Apr 19, 2016Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS9314195Aug 31, 2010Apr 19, 2016Abbott Diabetes Care Inc.Analyte signal processing device and methodsUS9314196Sep 7, 2012Apr 19, 2016Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibrationUS9314198Apr 3, 2015Apr 19, 2016Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9317656Nov 21, 2012Apr 19, 2016Abbott Diabetes Care Inc.Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereofUS9320461Sep 29, 2010Apr 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing notification function in analyte monitoring systemsUS9320462May 5, 2014Apr 26, 2016Abbott Diabetes Care Inc.Analyte sensor calibration managementUS9320468Jun 21, 2013Apr 26, 2016Abbott Diabetes Care Inc.Analyte sensor with time lag compensationUS9323898Nov 15, 2013Apr 26, 2016Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systemsUS9326707Nov 10, 2009May 3, 2016Abbott Diabetes Care Inc.Alarm characterization for analyte monitoring devices and systemsUS9326709Mar 9, 2011May 3, 2016Abbott Diabetes Care Inc.Systems, devices and methods for managing glucose levelsUS9326714Jun 29, 2010May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9326716Dec 5, 2014May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9326727May 15, 2014May 3, 2016Abbott Diabetes Care Inc.On-body medical device securementUS9328371Jul 16, 2013May 3, 2016Dexcom, Inc.Sensor head for use with implantable devicesUS9332933Sep 29, 2014May 10, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertionUS9332934Feb 8, 2013May 10, 2016Abbott Diabetes Care Inc.Analyte sensor with lag compensationUS9339217Nov 21, 2012May 17, 2016Abbott Diabetes Care Inc.Analyte monitoring system and methods of useUS9339222May 31, 2013May 17, 2016Dexcom, Inc.Particle-containing membrane and particulate electrode for analyte sensorsUS9339223Dec 30, 2013May 17, 2016Dexcom, Inc.Device and method for determining analyte levelsUS9339238May 16, 2012May 17, 2016Dexcom, Inc.Systems and methods for processing sensor dataUS9339612Dec 16, 2008May 17, 2016Sanofi-Aventis Deutschland GmbhTissue penetration deviceUS9351668Oct 12, 2009May 31, 2016Dexcom, Inc.Signal processing for continuous analyte sensorUS9351669Sep 30, 2010May 31, 2016Abbott Diabetes Care Inc.Interconnect for on-body analyte monitoring deviceUS9351680Oct 14, 2004May 31, 2016Sanofi-Aventis Deutschland GmbhMethod and apparatus for a variable user interfaceUS9357951Sep 29, 2010Jun 7, 2016Dexcom, Inc.Transcutaneous analyte sensorUS9357959Aug 19, 2013Jun 7, 2016Abbott Diabetes Care Inc.Method and system for dynamically updating calibration parameters for an analyte sensorUS9364149 *Oct 3, 2011Jun 14, 2016Abbott Diabetes Care Inc.Analyte sensor transmitter unit configuration for a data monitoring and management systemUS9364173Sep 23, 2009Jun 14, 2016Dexcom, Inc.Signal processing for continuous analyte sensorUS9375169Jan 29, 2010Jun 28, 2016Sanofi-Aventis Deutschland GmbhCam drive for managing disposable penetrating member actions with a single motor and motor and control systemUS9375529Sep 2, 2009Jun 28, 2016Becton, Dickinson And CompanyExtended use medical deviceUS9380971Dec 5, 2014Jul 5, 2016Abbott Diabetes Care Inc.Method and system for powering an electronic deviceUS9386944Apr 10, 2009Jul 12, 2016Sanofi-Aventis Deutschland GmbhMethod and apparatus for analyte detecting deviceUS9392969Aug 31, 2008Jul 19, 2016Abbott Diabetes Care Inc.Closed loop control and signal attenuation detectionUS9398872Aug 28, 2014Jul 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor calibrationUS9398882 *Sep 10, 2006Jul 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor and data processing deviceUS9402544 *Feb 1, 2010Aug 2, 2016Abbott Diabetes Care Inc.Analyte sensor and apparatus for insertion of the sensorUS9402570Dec 11, 2012Aug 2, 2016Abbott Diabetes Care Inc.Analyte sensor devices, connections, and methodsUS9402584Jan 14, 2015Aug 2, 2016Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS9408566Feb 13, 2013Aug 9, 2016Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring systemUS9410917Feb 28, 2014Aug 9, 2016Ascensia Diabetes Care Holdings AgMethod of using a biosensorUS20030153820 *Feb 12, 2003Aug 14, 2003Cygnus, Inc.Signal processing for measurement of physiological analytesUS20030153821 *Mar 7, 2003Aug 14, 2003Cygnus, Inc.Signal processing for measurement of physiological analytesUS20030217966 *May 22, 2002Nov 27, 2003Dexcom, Inc.Techniques to improve polyurethane membranes for implantable glucose sensorsUS20040010207 *Jul 15, 2002Jan 15, 2004Flaherty J. ChristopherSelf-contained, automatic transcutaneous physiologic sensing systemUS20040106858 *Nov 24, 2003Jun 3, 2004Therasense, Inc.Analyte monitoring device and methods of useUS20040120848 *Dec 20, 2002Jun 24, 2004Maria TeodorczykMethod for manufacturing a sterilized and calibrated biosensor-based medical deviceUS20040249253 *Aug 28, 2003Dec 9, 2004Joel RacchiniDevices, systems and methods for extracting bodily fluid and monitoring an analyte thereinUS20040253736 *Aug 28, 2003Dec 16, 2004Phil StoutAnalytical device with prediction module and related methodsUS20050027462 *Aug 1, 2003Feb 3, 2005Goode Paul V.System and methods for processing analyte sensor dataUS20050096519 *Aug 2, 2004May 5, 2005Denuzzio John D.Minimally-invasive system and method for monitoring analyte levelsUS20050126929 *Feb 2, 2005Jun 16, 2005Instrumentation LaboratoryAnalytical instruments, biosensors and methods thereofUS20050143636 *Dec 30, 2003Jun 30, 2005Medtronic Minimed, Inc.System and method for sensor recalibrationUS20050154271 *Nov 17, 2004Jul 14, 2005Andrew RasdalIntegrated receiver for continuous analyte sensorUS20050181012 *Jan 11, 2005Aug 18, 2005Sean SaintComposite material for implantable deviceUS20050239154 *Oct 27, 2004Oct 27, 2005Feldman Benjamin JA method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS20050245795 *May 3, 2004Nov 3, 2005Dexcom, Inc.Implantable analyte sensorUS20060015020 *Jul 6, 2004Jan 19, 2006Dexcom, Inc.Systems and methods for manufacture of an analyte-measuring device including a membrane systemUS20060020189 *Mar 10, 2005Jan 26, 2006Dexcom, Inc.Transcutaneous analyte sensorUS20060020192 *Mar 10, 2005Jan 26, 2006Dexcom, Inc.Transcutaneous analyte sensorUS20060200020 *May 2, 2006Sep 7, 2006Mark BristerTranscutaneous analyte sensorUS20060235285 *May 2, 2006Oct 19, 2006Mark BristerTranscutaneous analyte sensorUS20060264716 *Apr 25, 2006Nov 23, 2006Dennis ZanderMicroneedle with glucose sensor and methods thereofUS20060264888 *Aug 23, 2005Nov 23, 2006Medtronic Minimed, Inc.Reservoir support and method for infusion deviceUS20060264890 *Aug 23, 2005Nov 23, 2006Medtronic Minimed, Inc.Needle inserter and method for infusion deviceUS20060264894 *Aug 23, 2005Nov 23, 2006Medtronic Minimed, Inc.Infusion device and method with disposable portionUS20060270922 *May 23, 2006Nov 30, 2006Brauker James HAnalyte sensorUS20070038053 *Oct 19, 2006Feb 15, 2007Bret BernerSignal processing for measurement of physiological analytesUS20070045902 *May 23, 2006Mar 1, 2007Brauker James HAnalyte sensorUS20070059196 *Apr 26, 2006Mar 15, 2007Mark BristerAnalyte sensorUS20070126794 *Dec 5, 2005Jun 7, 2007Schick Karl GDisposable, pre-calibrated, pre-validated sensors for use in bio-processing applicationsUS20070149875 *Dec 28, 2005Jun 28, 2007Abbott Diabetes Care, Inc.Analyte monitoringUS20070154893 *Dec 29, 2005Jul 5, 2007Zhongping YangImplantable cell/tissue-based biosensing deviceUS20080027296 *Dec 10, 2004Jan 31, 2008Paul HadvaryDermally Affixed Sensor DeviceUS20080030738 *Aug 15, 2007Feb 7, 2008Biacore AbAnalytical method and apparatusUS20080039822 *Aug 22, 2007Feb 14, 2008Medtronic Minimed, Inc.System and method for sensor recalibrationUS20080051697 *Dec 8, 2006Feb 28, 2008Medtronic Minimed, Inc.Infusion medium delivery device and method with compressible or curved reservoir or conduitUS20080051698 *Dec 26, 2006Feb 28, 2008Medtronic Minimed, Inc.Infusion medium delivery device and method with compressible or curved reservoir or conduitUS20080051709 *Oct 27, 2006Feb 28, 2008Medtronic Minimed, Inc.Infusion medium delivery device and method with compressible or curved reservoir or conduitUS20080051710 *Nov 20, 2006Feb 28, 2008Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS20080051714 *Dec 26, 2006Feb 28, 2008Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS20080051716 *Nov 30, 2006Feb 28, 2008Medtronic Minimed, Inc.Infusion pumps and methods and delivery devices and methods with sameUS20080051718 *Dec 26, 2006Feb 28, 2008Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS20080051730 *Dec 26, 2006Feb 28, 2008Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS20080051738 *Dec 26, 2006Feb 28, 2008Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS20080051765 *Nov 20, 2006Feb 28, 2008Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS20080058726 *Aug 30, 2006Mar 6, 2008Arvind JinaMethods and Apparatus Incorporating a Surface Penetration DeviceUS20080064937 *Jun 7, 2007Mar 13, 2008Abbott Diabetes Care, Inc.Analyte monitoring system and methodUS20080071158 *Jun 7, 2007Mar 20, 2008Abbott Diabetes Care, Inc.Analyte monitoring system and methodUS20080077081 *Jun 7, 2007Mar 27, 2008Medtronic Minimed, Inc.Infusion medium delivery device and method with drive device for driving plunger in reservoirUS20080086273 *Mar 26, 2007Apr 10, 2008Dexcom, Inc.Analyte sensorUS20080097291 *Oct 27, 2006Apr 24, 2008Hanson Ian BInfusion pumps and methods and delivery devices and methods with sameUS20080097321 *Nov 20, 2006Apr 24, 2008Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS20080097328 *Nov 20, 2006Apr 24, 2008Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS20080097375 *Nov 30, 2006Apr 24, 2008Medtronic Minimed, Inc.Infusion pumps and methods and delivery devices and methods with sameUS20080097381 *Nov 22, 2006Apr 24, 2008Medtronic Minimed, Inc.Infusion medium delivery device and method with drive device for driving plunger in reservoirUS20080154107 *Dec 20, 2006Jun 26, 2008Jina Arvind NDevice, systems, methods and tools for continuous glucose monitoringUS20080161656 *Dec 28, 2007Jul 3, 2008Isense CorporationResposable biosensor assembly and methodUS20080214916 *Dec 21, 2007Sep 4, 2008Ofer YodfatFluid Delivery With In Vivo Electrochemical Analyte SensingUS20080242962 *Mar 20, 2008Oct 2, 2008Bernd RoesickeSystem for in-vitro measurement of an analyte concentrationUS20080269683 *Jul 11, 2008Oct 30, 2008Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS20080272007 *Oct 30, 2007Nov 6, 2008Therasense, Inc.Method of making an electrochemical sensorUS20080312518 *Jun 14, 2007Dec 18, 2008Arkal Medical, IncOn-demand analyte monitor and method of useUS20090018425 *Jul 3, 2008Jan 15, 2009Tianmei OuyangAnalyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agentUS20090069651 *Aug 8, 2008Mar 12, 2009The Regents Of The University Of CaliforniaMonitoring method and/or apparatusUS20090082728 *Nov 24, 2008Mar 26, 2009Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS20090145195 *Dec 13, 2006Jun 11, 2009Endress & Hauser Conducta Gesellschaft Fur Mess- Und Regeltechnik Mbh & Co. KgCalibration in a Laboratory Reference MethodUS20090145779 *Nov 14, 2008Jun 11, 2009Bayer Healthcare LlcRapid-Read Gated AmperometryUS20090163790 *Jan 23, 2009Jun 25, 2009Dexcom, Inc.Transcutaneous analyte sensorUS20090171291 *Jan 13, 2009Jul 2, 2009Medtronic Minimed, Inc.Systems and methods allowing for reservoir filling and infusion medium deliveryUS20090177406 *Dec 8, 2008Jul 9, 2009Bayer Healthcare LlcSlope-Based CompensationUS20090180513 *Jul 16, 2009Sencal LlcDisposable, pre-calibrated, pre-validated sensors for use in bio-processing applicationsUS20090192368 *Jul 30, 2009Abbott Diabetes Care Inc.Analyte Monitoring Device and Methods of UseUS20090240273 *Feb 11, 2009Sep 24, 2009Tyco Healthcare Group LpSurgical Introducer with IndicatorsUS20090242425 *Mar 25, 2008Oct 1, 2009Dexcom, Inc.Analyte sensorUS20090299301 *May 28, 2008Dec 3, 2009Medtronic Minimed, Inc.Needle protective device for subcutaneous sensorsUS20100032316 *Jul 10, 2009Feb 11, 2010Bayer Healthcare LlcSystems and Methods Including Amperometric and Voltammetric Duty CyclesUS20100049021 *Feb 25, 2010Jina Arvind NDevices, systems, methods and tools for continuous analyte monitoringUS20100099967 *Dec 21, 2009Apr 22, 2010Abbott Diabetes Care Inc.Analyte Monitoring Device and Methods of UseUS20100130943 *Jan 28, 2010May 27, 2010Medtronic Minimed, Inc.Infusion device and method with disposable portionUS20100169035 *Dec 29, 2008Jul 1, 2010Medtronic Minimed, Inc.Methods and systems for observing sensor parametersUS20100241065 *Sep 23, 2010Medtronic Minimed, Inc.Infusion Device with Base Portion and Durable PortionUS20100267161 *Oct 21, 2010Bayer Healthcare LlcMulti-Region and Potential Test Sensors, Methods, and SystemsUS20100292551 *Nov 18, 2010Jina Arvind NDevices, systems, methods and tools for continuous glucose monitoringUS20100324392 *Feb 1, 2010Dec 23, 2010Phillip YeeAnalyte sensor and apparatus for insertion of the sensorUS20100324853 *Jun 29, 2010Dec 23, 2010Medtronic Minimed, Inc.Real-time self-calibrating sensor system and methodUS20100331824 *Sep 3, 2010Dec 30, 2010Medtronic Minimed, Inc.Infusion medium delivery system, device and method with needle inserter and needle inserter device and methodUS20110077490 *Mar 31, 2011Dexcom, Inc.Transcutaneous analyte sensorUS20110082356 *Apr 7, 2011Medtronic Minimed, Inc.Analyte sensor apparatuses having interference rejection membranes and methods for making and using themUS20110105871 *Aug 4, 2010May 5, 2011The Regents Of The University Of CaliforniaMonitoring method and/or apparatusUS20110190614 *Aug 4, 2011Dexcom, Inc.Transcutaneous analyte sensorUS20110230741 *Sep 22, 2011Medtronic Minimed, Inc.Methods and systems for observing sensor parametersUS20110231105 *Sep 22, 2011Bayer Healthcare LlcResidual Compensation Including Underfill ErrorUS20120022346 *Jan 26, 2012Abbott Diabetes Care Inc.Analyte Sensor Transmitter Unit Configuration for a Data Monitoring and Management SystemUS20120029332 *Mar 15, 2010Feb 2, 2012Arkray, IncMethod of Continuously Measuring Substrate ConcentrationUS20140275897 *Mar 14, 2014Sep 18, 2014Sano Intelligence, Inc.On-body microsensor for biomonitoringUSRE43399Jun 13, 2008May 22, 2012Dexcom, Inc.Electrode systems for electrochemical sensorsUSRE44695May 1, 2012Jan 7, 2014Dexcom, Inc.Dual electrode system for a continuous analyte sensorCN100591265CDec 10, 2004Feb 24, 2010保罗�哈德瓦里Dermally affixed sensor deviceCN101563022BDec 20, 2007May 30, 2012梅丁格有限公司Fluid delivery with in vivo electrochemical analyte sensingCN102743179B *Dec 20, 2007Mar 16, 2016F�霍夫曼-拉罗氏股份公司带体内电化学分析物感测的流体传输EP1706022A1 †Dec 15, 2004Oct 4, 2006Medtronic MiniMed, Inc.System and method for sensor recalibrationEP2099362A1 *Dec 31, 2007Sep 16, 2009Isense CorporationResposable biosensor assembly and methodEP2228642A1 *Dec 7, 2004Sep 15, 2010DexCom, Inc.Systems and methods for improving electrochemical analyte sensorsEP2532305A1 *Jun 8, 2012Dec 12, 2012Dexcom, Inc.Transcutaneous analyte sensorEP2601883A1 *Dec 20, 2007Jun 12, 2013Medingo Ltd.Fluid delivery with in vivo electrochemical analyte sensingEP2959829A1 *Dec 28, 2009Dec 30, 2015Medtronic MiniMed, Inc.Methods and systems for observing sensor parametersWO2005012871A2 *Jul 21, 2004Feb 10, 2005Dexcom, Inc.Increasing bias for oxygen production in an electrode systemWO2005012871A3 *Jul 21, 2004Apr 14, 2005Dexcom IncIncreasing bias for oxygen production in an electrode systemWO2005063115A1 *Dec 10, 2004Jul 14, 2005Hadvary PaulDermallly affixed sensor deviceWO2007067881A2 *Dec 4, 2006Jun 14, 2007Sencal LlcDisposable conductivity sensor comprising memory means and temperature sensor for calibrationWO2007067881A3 *Dec 4, 2006Jul 26, 2007Sencal LlcDisposable conductivity sensor comprising memory means and temperature sensor for calibrationWO2007076303A1 *Dec 15, 2006Jul 5, 2007Medtronic, Inc.Implantable cell/tissue-based biosensing deviceWO2008078319A1 *Dec 20, 2007Jul 3, 2008Medingo Ltd.Fluid delivery with in vivo electrochemical analyte sensingWO2010078263A3 *Dec 28, 2009Dec 2, 2010Medtronic Minimed, Inc.Methods and systems for observing sensor parameters* Cited by examiner, † Cited by third partyClassifications U.S. Classification600/345, 600/309, 600/347International ClassificationG01N27/26, G01N27/327, A61B5/00, G01N27/416, C12Q1/00, G01N33/487Cooperative ClassificationA61B5/6848, C12Q1/006, A61B5/1495, A61B5/14865European ClassificationA61B5/1495, A61B5/1486B, A61B5/68D1B, C12Q1/00B6BLegal EventsDateCodeEventDescriptionJan 29, 1999ASAssignmentOwner name: ELAN CORPORATION, PLC, IRELANDFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ELAN MEDICAL TECHNOLOGIES LIMITED;REEL/FRAME:009719/0946Effective date: 19981210Feb 14, 2005FPAYFee paymentYear of fee payment: 4Feb 17, 2009FPAYFee paymentYear of fee payment: 8Jul 6, 2010ASAssignmentOwner name: ELAN PHARMA INTERNATIONAL LIMITED, IRELANDFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ELAN CORPORATION, PLC;REEL/FRAME:024640/0053Effective date: 20061231Sep 29, 2011ASAssignmentOwner name: MORGAN STANLEY SENIOR FUNDING, INC., NEW YORKFree format text: PATENT SECURITY AGREEMENT (FIRST LIEN);ASSIGNORS:ALKERMES, INC.;ALKERMES PHARMA IRELAND LIMITED;ALKERMES CONTROLLED THERAPEUTICS INC.;REEL/FRAME:026994/0186Effective date: 20110916Owner name: MORGAN STANLEY SENIOR FUNDING, INC., NEW YORKFree format text: PATENT SECURITY AGREEMENT (SECOND LIEN);ASSIGNORS:ALKERMES, INC.;ALKERMES PHARMA IRELAND LIMITED;ALKERMES CONTROLLED THERAPEUTICS INC.;REEL/FRAME:026994/0245Effective date: 20110916Nov 8, 2011CCCertificate of correctionSep 25, 2012ASAssignmentOwner name: EDT PHARMA HOLDINGS LIMITED, IRELANDFree format text: ASSET TRANSFER AGREEMENT;ASSIGNOR:ELAN PHARMA INTERNATIONAL LIMITED;REEL/FRAME:029033/0396Effective date: 20110802Owner name: ALKERMES PHARMA IRELAND LIMITED, IRELANDFree format text: CHANGE OF NAME;ASSIGNOR:EDT PHARMA HOLDINGS LIMITED;REEL/FRAME:029034/0023Effective date: 20110914Owner name: EDT PHARMA HOLDINGS, IRELANDFree format text: NOTICE OF CHANGE IN REGISTERED OFFICE ADDRESS;ASSIGNOR:EDT PHARMA HOLDINGS;REEL/FRAME:029033/0438Effective date: 20110815Owner name: ALKERMES PHARMA IRELAND LIMITED, IRELANDFree format text: NOTICE OF CHANGE IN REGISTERED OFFICE ADDRESS;ASSIGNOR:ALKERMES PHARMA IRELAND LIMITED;REEL/FRAME:029034/0101Effective date: 20120223Oct 2, 2012FPAYFee paymentYear of fee payment: 12Oct 12, 2012ASAssignmentOwner name: ALKERMES CONTROLLED THERAPEUTICS INC., MASSACHUSETFree format text: RELEASE BY SECURED PARTY (SECOND LIEN);ASSIGNOR:MORGAN STANLEY SENIOR FUNDING, INC.;REEL/FRAME:029116/0379Effective date: 20120924Owner name: ALKERMES, INC., MASSACHUSETTSFree format text: RELEASE BY SECURED PARTY (SECOND LIEN);ASSIGNOR:MORGAN STANLEY SENIOR FUNDING, INC.;REEL/FRAME:029116/0379Effective date: 20120924Owner name: ALKERMES PHARMA IRELAND LIMITED, IRELANDFree format text: RELEASE BY SECURED PARTY (SECOND LIEN);ASSIGNOR:MORGAN STANLEY SENIOR FUNDING, INC.;REEL/FRAME:029116/0379Effective date: 20120924RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services